Menu
Live
Kongressberichte
Aktuelle Kongressberichte
ESMO Congress 2024 - 13. - 17. SEPTEMBER - BARCELONA, SPANIEN
IASLC 2024 World Conference on Lung Cancer
ESMO Gastrointestinal Cancers Congress 2024
EHA2024 Hybrid Congress - Madrid, June 13-16, 2024.
ASCO Annual Meeting 2024 May 31 - June 4, 2024 - McCormick Place, Chicago
ESGO - 25th European Congress on Gynaecological Oncology
EBMT-EHA 6th European CAR T-cell Meeting
ASCO Genitourinary Cancers Symposium
ASCO 2024 Gastrointestinal (GI) Cancers Symposium
Kongressberichte 2023
65th ASH Annual Meeting and Exposition - December 09-12, 2023
46th SAN ANTONIO BREAST CANCER SYMPOSIUM - December 5 - 9, 2023, San Antonio Texas
ESMO Congress 2023 - 20. - 24. OKTOBER - MADRID, SPANIEN
IASLC 2023 World Conference on Lung Cancer
ESMO World Congress on Gastrointestinal Cancer (ESMO World GI 2023)
EHA2023 Congress
ASCO Annual Meeting, June 2-6, 2023 - McCormick Place, Chicago
Comprehensive Cancer Center Zürich: Patientenakademie – Brustkrebs
18th St.Gallen International Breast Cancer Conference 2023 (SGBCC)
ASCO Genitourinary Cancers Symposium 2023
ASCO 2023 Gastrointestinal (GI) Cancers Symposium
Kongressberichte 2022
64th ASH Annual Meeting and Exposition - December 10-13, 2022
45th SAN ANTONIO BREAST CANCER SYMPOSIUM - December 6 - 10, 2022, San Antonio Texas
Cancer Academy Multiples Myelom
ESMO Congress 2022 - 9. - 13. SEPTEMBER - PARIS, FRANCE
19th International Myeloma Society Annual Meeting - Los Angeles, August 25-27, 2022
World Conference on Lung Cancer - AUGUST 6 - 9, 2022, VIENNA, AUSTRIA
ESMO World Congress on Gastrointestinal Cancer (ESMO World GI 2022)
EHA2022 Congress
ASCO Annual Meeting, June 3-7, 2022 - McCormick Place, Chicago
SAMO Interdisciplinary Workshop on Breast Tumors 2022
Druggable in 2022: Wie neue zielgerichtete Therapien die Behandlung bei fortgeschrittenem NSCLC verändern
3rd European Myeloma Network Meeting
AGO - MAMMAKARZINOM STATE OF THE ART
Wie neue zielgerichtete Therapien die Behandlung beim fortgeschrittenen NSCLC (r)evolutionieren.
EBMT (48th Annual Meeting of the European Society for Blood and Marrow Transplantation)
SAMO Highlights of the Year 2021
Brustrebsinfotag
SAMO Masterclass I 2022
ASCO Genitourinary Cancers Symposium 2022
EBMT-EHA 4th European CAR T-Cell Meeting
ASCO Gastrointestinal Cancers Symposium
Archiv Kongressberichte
63rd ASH Annual Meeting and Exposition - December 11-14, 2021
SAN ANTONIO BREAST CANCER SYMPOSIUM - December 7 - 11, 2021, San Antonio Texas
9. Interdisziplinäres Prostatakarzinom-Symposium, St. Gallen, 2. Dezember 2021
Kongressberichte Archiv 2021
Kongressberichte Archiv 2020
Kongressberichte Archiv 2019
Kongressberichte Archiv 2018
Kongressberichte Archiv 2017
Kalender
Krebstherapie
Alle Wirkstoffe
Behandlungsguidelines
Link to Medical Journals
Interaktionsprüfungen
Cancer Cell Line Encyclopedia
Krebserkrankungen (Entstehung, Verlauf, Therapie & Prävention)
Organisationen
Netzwerke
Fachgesellschaften
Info für PatientINNen
Science Board
Datenschutzbestimmungen
Impressum
Zustimmen
Nicht zustimmen
ESMO 2024 Press Briefing Recordings
Oncoletter
Kongressberichte
2024
ESMO Congress 2024 - 13. - 17. SEPTEMBER - BARCELONA, SPANIEN
ESMO 2024 Press Conference Recording
ESMO 2024 Press Conference Recordings
ESMO 2024 Opening Press Conference
ESMO 2024 Opening Press Conference
Das Laden von Vimeo wurde nicht erlaubt. Bitte ändern Sie die
Datenschutz-Einstellungen
Copyright 2024. All Rights Reserved.
Datenschutzbestimmungen
Live
Kongressberichte
2024
ESMO Congress 2024 - 13. - 17. SEPTEMBER - BARCELONA, SPANIEN
IASLC 2024 World Conference on Lung Cancer
ESMO Gastrointestinal Cancers Congress 2024
EHA2024 Hybrid Congress - Madrid, June 13-16, 2024.
ASCO Annual Meeting 2024 May 31 - June 4, 2024 - McCormick Place, Chicago
ESGO - 25th European Congress on Gynaecological Oncology
EBMT-EHA 6th European CAR T-cell Meeting
ASCO Genitourinary Cancers Symposium
ASCO 2024 Gastrointestinal (GI) Cancers Symposium
2023
65th ASH Annual Meeting and Exposition - December 09-12, 2023
46th SAN ANTONIO BREAST CANCER SYMPOSIUM - December 5 - 9, 2023, San Antonio Texas
ESMO Congress 2023 - 20. - 24. OKTOBER - MADRID, SPANIEN
IASLC 2023 World Conference on Lung Cancer
ESMO World Congress on Gastrointestinal Cancer (ESMO World GI 2023)
EHA2023 Congress
ASCO Annual Meeting, June 2-6, 2023 - McCormick Place, Chicago
Comprehensive Cancer Center Zürich: Patientenakademie – Brustkrebs
18th St.Gallen International Breast Cancer Conference 2023 (SGBCC)
ASCO Genitourinary Cancers Symposium 2023
ASCO 2023 Gastrointestinal (GI) Cancers Symposium
2022
64th ASH Annual Meeting and Exposition - December 10-13, 2022
45th SAN ANTONIO BREAST CANCER SYMPOSIUM - December 6 - 10, 2022, San Antonio Texas
Cancer Academy Multiples Myelom
ESMO Congress 2022 - 9. - 13. SEPTEMBER - PARIS, FRANCE
19th International Myeloma Society Annual Meeting - Los Angeles, August 25-27, 2022
World Conference on Lung Cancer - AUGUST 6 - 9, 2022, VIENNA, AUSTRIA
ESMO World Congress on Gastrointestinal Cancer (ESMO World GI 2022)
EHA2022 Congress
ASCO Annual Meeting, June 3-7, 2022 - McCormick Place, Chicago
SAMO Interdisciplinary Workshop on Breast Tumors 2022
Druggable in 2022: Wie neue zielgerichtete Therapien die Behandlung bei fortgeschrittenem NSCLC verändern
3rd European Myeloma Network Meeting
AGO - MAMMAKARZINOM STATE OF THE ART
Wie neue zielgerichtete Therapien die Behandlung beim fortgeschrittenen NSCLC (r)evolutionieren.
EBMT (48th Annual Meeting of the European Society for Blood and Marrow Transplantation)
SAMO Highlights of the Year 2021
Brustrebsinfotag
SAMO Masterclass I 2022
ASCO Genitourinary Cancers Symposium 2022
EBMT-EHA 4th European CAR T-Cell Meeting
ASCO Gastrointestinal Cancers Symposium
2021
63rd ASH Annual Meeting and Exposition - December 11-14, 2021
SAN ANTONIO BREAST CANCER SYMPOSIUM - December 7 - 11, 2021, San Antonio Texas
9. Interdisziplinäres Prostatakarzinom-Symposium, St. Gallen, 2. Dezember 2021
Kongressberichte Archiv 2021
Kongressberichte Archiv 2020
Kongressberichte Archiv 2019
Kongressberichte Archiv 2018
Kongressberichte Archiv 2017
Kalender
Krebstherapie
Alle Wirkstoffe
Behandlungsguidelines
Link to Medical Journals
Interaktionsprüfungen
Cancer Cell Line Encyclopedia
Krebserkrankungen (Entstehung, Verlauf, Therapie & Prävention)
Organisationen
Netzwerke
Fachgesellschaften
Info für PatientINNen
Science Board
Menu
Live
Kongressberichte
Aktuelle Kongressberichte
ESMO Congress 2024 - 13. - 17. SEPTEMBER - BARCELONA, SPANIEN
IASLC 2024 World Conference on Lung Cancer
ESMO Gastrointestinal Cancers Congress 2024
EHA2024 Hybrid Congress - Madrid, June 13-16, 2024.
ASCO Annual Meeting 2024 May 31 - June 4, 2024 - McCormick Place, Chicago
ESGO - 25th European Congress on Gynaecological Oncology
EBMT-EHA 6th European CAR T-cell Meeting
ASCO Genitourinary Cancers Symposium
ASCO 2024 Gastrointestinal (GI) Cancers Symposium
Kongressberichte 2023
65th ASH Annual Meeting and Exposition - December 09-12, 2023
46th SAN ANTONIO BREAST CANCER SYMPOSIUM - December 5 - 9, 2023, San Antonio Texas
ESMO Congress 2023 - 20. - 24. OKTOBER - MADRID, SPANIEN
IASLC 2023 World Conference on Lung Cancer
ESMO World Congress on Gastrointestinal Cancer (ESMO World GI 2023)
EHA2023 Congress
ASCO Annual Meeting, June 2-6, 2023 - McCormick Place, Chicago
Comprehensive Cancer Center Zürich: Patientenakademie – Brustkrebs
18th St.Gallen International Breast Cancer Conference 2023 (SGBCC)
ASCO Genitourinary Cancers Symposium 2023
ASCO 2023 Gastrointestinal (GI) Cancers Symposium
Kongressberichte 2022
64th ASH Annual Meeting and Exposition - December 10-13, 2022
45th SAN ANTONIO BREAST CANCER SYMPOSIUM - December 6 - 10, 2022, San Antonio Texas
Cancer Academy Multiples Myelom
ESMO Congress 2022 - 9. - 13. SEPTEMBER - PARIS, FRANCE
19th International Myeloma Society Annual Meeting - Los Angeles, August 25-27, 2022
World Conference on Lung Cancer - AUGUST 6 - 9, 2022, VIENNA, AUSTRIA
ESMO World Congress on Gastrointestinal Cancer (ESMO World GI 2022)
EHA2022 Congress
ASCO Annual Meeting, June 3-7, 2022 - McCormick Place, Chicago
SAMO Interdisciplinary Workshop on Breast Tumors 2022
Druggable in 2022: Wie neue zielgerichtete Therapien die Behandlung bei fortgeschrittenem NSCLC verändern
3rd European Myeloma Network Meeting
AGO - MAMMAKARZINOM STATE OF THE ART
Wie neue zielgerichtete Therapien die Behandlung beim fortgeschrittenen NSCLC (r)evolutionieren.
EBMT (48th Annual Meeting of the European Society for Blood and Marrow Transplantation)
SAMO Highlights of the Year 2021
Brustrebsinfotag
SAMO Masterclass I 2022
ASCO Genitourinary Cancers Symposium 2022
EBMT-EHA 4th European CAR T-Cell Meeting
ASCO Gastrointestinal Cancers Symposium
Archiv Kongressberichte
63rd ASH Annual Meeting and Exposition - December 11-14, 2021
SAN ANTONIO BREAST CANCER SYMPOSIUM - December 7 - 11, 2021, San Antonio Texas
9. Interdisziplinäres Prostatakarzinom-Symposium, St. Gallen, 2. Dezember 2021
Kongressberichte Archiv 2021
Kongressberichte Archiv 2020
Kongressberichte Archiv 2019
Kongressberichte Archiv 2018
Kongressberichte Archiv 2017
Kalender
Krebstherapie
Alle Wirkstoffe
Behandlungsguidelines
Link to Medical Journals
Interaktionsprüfungen
Cancer Cell Line Encyclopedia
Krebserkrankungen (Entstehung, Verlauf, Therapie & Prävention)
Organisationen
Netzwerke
Fachgesellschaften
Info für PatientINNen
Science Board
Datenschutzbestimmungen
Impressum
Zustimmen
Nicht zustimmen
Live
Kongressberichte
2024
ESMO Congress 2024 - 13. - 17. SEPTEMBER - BARCELONA, SPANIEN
ESMO 2024 Press Conference Recording
ESMO24 - Presidential Symposia I-III
ESMO24 - Presidential Symposia I-III
Presidential Symposium I: Practice-changing trials: Sat, 14.09.24; 16:30 - 18:15; Room Barcelona Auditorium - Hall 2
Presidential Symposium II: Practice-changing trials; Sun, 15.09.24; 16:30 - 18:15; Room Barcelona Auditorium Hall 2
Presidential Symposium III: Eyes to the future; Mon, 16.09.24; 16:30 - 18:15 Room Barcelona Auditorium - Hall 2
BREAST CANCER
Interviews
Breast cancer, early stage
Breast cancer, metastatic
LUNG CANCER & OTHER THORACIC MALIGNANCIES
Non-metastatic NSCLC and other thoracic malignancies
NSCLC, metastatic
HEAD & NECK CANCER
Head & Neck Sessions
GYNAECOLOGICAL CANCERS
Gynaecological Sessions
CNS TUMOURS & SARCOMA
CNS & SARCOMA Sessions
GENITOURINARY TUMOURS
Statement Highlights Urothel- und Nierenzellkarzinom: OÄ Dr. Dora Niedersüß-Beke, MBA
GU tumours, non-prostate
GU tumours, prostate
GASTROINTESTINAL TUMOURS
Statement Assoc.-Prof. Priv.-Doz. Dr. Gerald Prager: Neues bei gastrointestinalen Tumoren
GI, upper digestive
GI, lower digestive
NETs and endocrine tumours
NETs and endocrine tumours Sessions
HAEMATOLOGICAL MALIGNANCIES
Haematological malignancies Sessions
MELANOMA AND OTHER SKIN TUMOURS
Kommentare Prof. Roger von Moos, Direktor Tumor- und Forschungszentrum, Kantonsspital Graubünden, Chur
Melanoma Sessions
INVESTIGATIONAL IMMUNOTHERAPY
INVESTIGATIONAL IMMUNOTHERAPY
SUPPORTIVE AND PALLIATIVE CARE
Supportive and palliative care sessions
BASIC SCIENCE & TRANSLATIONAL RESEARCH & DEVELOPMENTAL THERAPEUTICS
Basic science & translational research sessions & developmental therapeutics
IASLC 2024 World Conference on Lung Cancer
IASLC World Conference on Lung Cancer Press Briefing Recordings
PL02 Presidential Symposium 1
PL04 Presidential Symposium 2
OA01. Perioperative Strategies 1 - Sep 8 2024 - 10:45AM - 12:00PM - Room 20A
OA02. Redefining First-Line EGFR Therapy - Sep 8 2024 - 10:45AM - 12:00PM - Room 20D
OA04. Antibody Drug Conjugates in SCLC - Sep 8 2024 - 2:00PM - 3:15PM - Room 20A
OA05. Local Consolidative Therapy for Metastatic NSCLC - Sep 8 2024 - 2:00PM - 3:15PM - Room 32AB
OA06. Novel Immunotherapy Strategies and Combinations - Sep 8 2024 - 3:30PM - 4:45PM - Room 20BC
OA08. The New Generation of Cytotoxics - Sep 9 2024 - 10:45AM - 12:00PM - Room 20A
OA09. Trailblazing Targets: New Insights - Sep 9 2024 - 10:45AM - 12:00PM - Room 20D
OA10. DLL3 Targeting BiTE Therapies in SCLC - Sep 9 2024 - 2:00PM - 3:15PM - Room 20A
OA11. Shifting the Bar in the Front Line Immunotherapy Setting - Sep 9 2024 - 2:00PM - 3:15PM - Room 20BC
OA12. Advancing Multimodal Therapies in Stage III NSCLC - Sep 9 2024 - 2:00PM - 3:15PM - Room 32AB
OA13. Perioperative Strategies 2 - Sep 9 2024 - 3:30PM - 4:45PM - Room 20A
OA14. New Horizons in Targeting KRAS G12C - Sep 9 2024 - 3:30PM - 4:45PM - Room 20D
OA16. Transforming Cancer Therapy: Biomarkers and Novel ADCs - Sep 10 2024 - 1:30PM - 2:45PM - Room 20A
OA18. Pleural, Mediastinal and Undifferentiated Thoracic Cancers - Sep 10 2024 - 3:00PM - 4:15PM - Room 30BC
More Links to Oral Sessions
MA01. Advances in Treatment for Stage III NSCLC - Sep 8 2024 - 2:00PM - 3:15PM - Room 20BC
MA06. New Strategies in ALK, ROS1, NTRK, BRAF, and MET NSCLC - Sep 10 2024 - 11:15AM - 12:30PM - Room 20D
MA11. Building on the Foundations of Current Immunotherapies - Sep 10 2024 - 1:30PM - 2:45PM - Room 20BC
MA12. Paving the Path to Precision Oncology: Targeting EGFR and HER2 - Sep 10 2024 - 1:30PM - 2:45PM - Room 20D
MA16. Strategies Beyond Current Immunotherapies - Sep 10 2024 - 3:00PM - 4:15PM - Room 20BC
MA17. Limited-stage SCLC, Novel Immunotherapy Combinations and Biomarkers in SCLC - Sep 10 2024 - 3:00PM - 4:15PM -Room 20D
More Links to Mini Oral Sessions
ESMO Gastrointestinal Cancers Congress 2024
Proffered Paper Session
Proffered Paper Session
Mini Oral Sessions
Mini Oral sessions
EHA2024 Hybrid Congress - Madrid, June 13-16, 2024.
Plenary and Late Breaking Abstract Sessions
Plenary and Late Breaking Abstract Sessions
Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia
Acute Myeloid Leukemia
Acute myeloid leukemia
Aggressive Non-Hodgkin lymphoma
Aggressive Non-Hodgkin lymphoma
Chronic Lymphocytic Leukemia and Related disorders
Chronic lymphocytic leukemia and related disorders
Chronic Myeloid Leukemia
Chronic Myeloid Leukemia
Hodgkin Lymphoma
Hodgkin lymphoma
Myelodysplastic Syndromes
Myelodysplastic Syndromes
Indolent and Mantle-cell non-Hodgkin Lymphoma
Indolent and Mantle-cell non-Hodgkin Lymphoma
Myeloma and other monoclonal gammopathies
Frontline therapy for MM
CAR T cell therapy for the treatment of Multiple Myeloma
Novel agents in RRMM
Myeloproliferative Neoplasms
Myeloproliferative Neoplasms
Gene Therapy
Stem cell transplantation - Clinical and cell therapy
Cellular Immunotherapy and Vaccination - Biology & Translational Research
Cellular Immunotherapy and Vaccination
ASCO Annual Meeting 2024 May 31 - June 4, 2024 - McCormick Place, Chicago
Saturday, June 1 - Press Briefings
Interviews in Kooperation mit info@ONCO-SUISSE, moderiert von Prof. Roger von Moos: Schweizer Experten fassen die ASCO Ergebnisse zusammen
Round Table und Interviews von Renate Haidinger, Brustkrebs Deutschland e.V.
Plenary session
Plenary Session Late breaking abstracts - Sunday, June 3, 1PM-4PM, Hall B1
Schweizer Beiträge am ASCO 2024
Links to all Poster Sessions
Breast Cancer
Breast Cancer—Local/Regional/Adjuvant
Breast Cancer—Metastatic
Lung Cancer
Lung Cancer - Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Lung Cancer—Non-Small Cell Metastatic
Gastrointestinal Cancer
Gastrointestinal Cancer—Colorectal and Anal
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Genitourinary Cancer
Genitourinary Cancer—Kidney and Bladder
Genitourinary Cancer—Prostate, Testicular, and Penile
Gynecologic Cancer
Gynecologic Cancer
Central Nervous System Tumors
Central Nervous System Tumors
Head and Neck Cancer
Head and Neck Cancer
Melanoma/Skin Cancers
Melanoma/Skin Cancers
Sarcoma
Sarcoma
Pediatric Oncology
Pediatric Oncology
Hematologic Malignancies
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Hematologic Malignancies—Plasma Cell Dyscrasia
Developmental Therapeutics
Developmental Therapeutics—Immunotherapy
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
ESGO - 25th European Congress on Gynaecological Oncology
Best Oral Session - Late Breaking Abstracts
Best Oral Session - Cervical Cancer
Mini Oral Session - Cervical Cancer
Best Oral Session - Endometrial Cancer
Mini Oral Session - Endometrial Cancer
Best Oral Session - Ovarian Cancer
Mini Oral Session - Ovarian Cancer
Mini Oral Session - Miscellaneous Cancers
Young Investigator Session
Best Three Minutes Presentations
EBMT-EHA 6th European CAR T-cell Meeting
EBMT-EHA 6th European CAR T-cell Meetings Best Abstracts
ASCO Genitourinary Cancers Symposium
Rapid Oral Abstract Sessions
Rapid Oral Abstract Sessions
Oral Abstract Sessions
Oral Abstract Sessions
Trials in Progress Poster Sessions
Trials in Progress Poster Sessions
ASCO 2024 Gastrointestinal (GI) Cancers Symposium
Rapid Oral Abstract Sessions
Rapid Abstract Sessions
Oral Abstract Sessions
Oral Abstract Sessions
Trials in Progress Poster Sessions
Trials in Progress Poster Sessions
2023
65th ASH Annual Meeting and Exposition - December 09-12, 2023
ASH Press Briefings on Late Breaking and other important Abstracts
ASH Press Briefings
Late-Breaking Abstracts Session
Acute Lymphoblastic Leukemias
ALL: Clinical and Epidemiological studies
ALL: Therapies, Excluding Transplantation and Cellular Immunotherapies
Acute Myeloid Leukemias
AML: Clinical and Epidemiological studies
AML: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies
AML: Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies
AML: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis
Chronic Myeloid Leukemia
CML: Clinical and Epidemiological studies
Myeloproliferative Syndromes and Chronic Myeloid Leukemia
MPS and CML: Basic and Translational
MPS: Clinical and Epidemiological
Lymphomas
Lymphomas: Translational
Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas
Hodgkin Lymphomas and T/NK cell Lymphomas
Aggressive Lymphomas
Chronic Lymphocytic Leukemias
CLL
Myelodysplastic Syndromes
MDS
Multiple Myeloma and Plasma Cell Dyscrasias
Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational
Multiple Myeloma: Clinical and Epidemiological
Multiple Myeloma: Prospective Therapeutic Trials
MGUS, Amyloidosis and Other Non-Myeloma Plasma Cell Dyscrasias
Cellular Immunotherapies
Cellular Immunotherapies: Late Phase and Commercially Available Therapies
46th SAN ANTONIO BREAST CANCER SYMPOSIUM - December 5 - 9, 2023, San Antonio Texas
Studies presented at the SABCS 2023 Press Briefing
Interviews von Renate Haidinger, Brustkrebs Deutschland e.V.
Kurze Videos mit Expert:innen zu ausgewählten Highlights aus Sitzungen und Vorträgen sowie speziellen Schwerpunktthemen
General Sessions 1-3
General Sessions
Rapid Fire Sessions 1&2
Rapid Fire Sessions 1&2
Late Breaking Abstracts Oral Session
Late Breaking Abstracts Oral Session
POSTER SPOTLIGHT SESSIONS 1-18
POSTER SPOTLIGHT SESSIONS
ESMO Congress 2023 - 20. - 24. OKTOBER - MADRID, SPANIEN
ESMO23 - Presidential Symposia I-III
ESMO23 - Presidential Symposia I-III
BREAST CANCER
Interviews
Breast cancer, early stage
Breast cancer, metastatic.
LUNG CANCER & OTHER THORACIC MALIGNANCIES
Statement ESMO Highlights Lungenkrebs Prof. Dr. med. Alessandra Curioni-Fontecedro, Fribourg
Non-metastatic NSCLC and other thoracic malignancies
NSCLC, metastatic
HEAD & NECK CANCER
Statement Highlights Head and Neck Cancer - Assoz.-Prof. Priv.-Doz. Dr. Thorsten Füreder, Wien
Head & Neck Sessions
GYNAECOLOGICAL CANCERS
Interviews von Renate Haidinger, Brustkrebs Deutschland e.V. mit Prof. Dr. med. Sven Mahner - Highlights Gynäkologische Tumoren
Gynaecological Sessions
CNS TUMOURS & SARCOMA
CNS & SARCOMA Sessions
GENITOURINARY TUMOURS
GU tumours, non-prostate.
GU tumours, prostate
GASTROINTESTINAL TUMOURS
GI, upper digestive
GI, lower digestive
NETs and endocrine tumours
NETs and endocrine tumours Sessions
HAEMATOLOGICAL MALIGNANCIES
Haematological malignancies Sessions
MELANOMA AND OTHER SKIN TUMOURS
Melanoma Sessions
INVESTIGATIONAL IMMUNOTHERAPY
INVESTIGATIONAL IMMUNOTHERAPY
BASIC SCIENCE & TRANSLATIONAL RESEARCH & DEVELOPMENTAL THERAPEUTICS (Kopie)
Basic science & translational research sessions & developmental therapeutics
SUPPORTIVE AND PALLIATIVE CARE
Supportive and palliative care sessions
IASLC 2023 World Conference on Lung Cancer
IASLC World Conference on Lung Cancer Press Briefing Recordings
Oral Session: Advancing Immunotherapy in ES-SCLC
Oral Session: Evolving Landscape in Mesothelioma
Oral Session: Newer Generation Treatments for EGFR, ALK and ROS1
Oral Session: Antibody Drug Conjugates: The Next Tsunami
Oral Session: Immunotherapy for Advanced NSCLC
Oral Session: Pushing the Boundaries: Adjuvant & Neoadjuvant Approaches in Early NSCLC
Oral Session: Immune Checkpoint Therapy: Long Term Follow Up
Oral Session: MET Matters in NSCLC
Oral Session: Integration of Local Therapies with Modern Immune Checkpoint Inhibitors and Targeted Therapies in Metastatic NSCLC: When and How?
Oral Session: Next Steps in Locally Advanced NSCLC: Optimizing Techniques & Choosing Populations That Benefit
More Links to Oral Sessions
Mini Oral Session: Targeted Therapy: KRAS and Beyond
Mini Oral Session: Mediastinal Lumps and Bumps
Mini Oral Session: New Technology and Innovations in Early Stage Lung Cancer
Mini Oral Session: Targeted Therapy: EGFR and HER2
Mini Oral Session: Bringing New Discoveries into Early Phase Clinical Trials
Mini Oral Session: Innovations in the Treatment of Stage III NSCLC
Mini Oral Session: Current Standards and Future Directions in Mesothelioma
Mini Oral Session: Refining Practice and Redefining Standards in SCLC
More Links to Mini Oral Sessions
ESMO World Congress on Gastrointestinal Cancer (ESMO World GI 2023)
Session II: Cancer of the Pancreas
Session III: Cancer of the Biliary Tract
Session V: Presentation of Selected Abstracts – Biliary Tract and Pancreatic Cancer
Session VI: Presentation of Selected Abstracts - Esophageal and Stomach Cancers
Session VIII: Esophageal and Gastric Cancers
Session IX: Hepatocellular Cancer
Session XI: Presentation of Selected Abstracts: Colorectal Cancer
Session XVIII: Immune Mechanisms and Microbiome in GI Tumors
Session XIX: Predicting and Managing Rare Toxicities in Patients With GI Cancers
Session XX: Presentation of Selected Abstracts: Metastatic Colorectal Cancer
Session XXIII: Colorectal Cancer: Metastatic Disease
EHA2023 Congress
Plenary Session
EHA 2023 Press Briefing, Friday, June 9
Late Breaking Abstracts Session
Acute lymphoblastic leukemia
Acute myeloid leukemia
Aggressive Non-Hodgkin lymphoma
Chronic lymphocytic leukemia
Chronic myeloid leukemia
Myeloma and other monoclonal gammopathies - Clinical
Gene therapy, cellular immunotherapy and vaccination
Hodgkin lymphoma
Indolent and mantle-cell non-Hodgkin lymphoma/Waldenström
Myelodysplastic syndromes
Myeloproliferative neoplasms
Stem cell transplantation
ASCO Annual Meeting, June 2-6, 2023 - McCormick Place, Chicago
Late-Breaking Abstract -, Plenary - & Highlights of the Day Sessions
Interviews in Kooperation mit info@ONCO-SUISSE, moderiert von Prof. Roger von Moos: Schweizer Experten fassen die ASCO Ergebnisse zusammen
Round Table und Interviews von Renate Haidinger, Brustkrebs Deutschland e.V.
Saturday, June 3 & Sunday June 4, On-Site Press Briefings
Lung Cancer: Oral & Poster Discussion Sessions
Head and Neck Cancer: Oral & Poster Discussion Sessions
Breast Cancer: Oral & Poster Discussion Sessions
Gynecologic Cancer: Oral & Poster Discussion Sessions
Gastrointestinal Cancer: Oral & Poster Discussion Sessions
Sarcoma Cancer: Oral & Poster Discussion Sessions.
Melanoma/Skin Cancers: Oral & Poster Discussion Sessions.
Central Nervous System Tumors: Oral & Poster Discussion Sessions.
Genitourinary Cancer: Oral & Poster Discussion Sessions
Hematologic Malignancies: Oral & Poster Discussion Sessions
Developmental Therapeutics: Oral & Poster Discussion Sessions
Pediatric Oncology: Oral & Poster Discussion Sessions
Comprehensive Cancer Center Zürich: Patientenakademie – Brustkrebs
Neuigkeiten in der Behandlung und Nachsorge bei Brustkrebs
18th St.Gallen International Breast Cancer Conference 2023 (SGBCC)
Interviews von Renate Haidinger, Brustkrebs Deutschland e.V. mit:
ASCO Genitourinary Cancers Symposium 2023
General Sessions
Rapid Abstract Sessions
Oral Abstract Sessions
Statements zu den Highlights des ASCO-GU
ASCO 2023 Gastrointestinal (GI) Cancers Symposium
Rapid Abstract Sessions
Oral Abstract Sessions
Links to more Abstracts
2022
64th ASH Annual Meeting and Exposition - December 10-13, 2022
Plenary Scientific Session
Late-Breaking Abstracts Session
Press Briefing
ASH 2022 Press Briefings: Treating Blood Cancers: Changing the Status Quo & New Drugs, New Targets
ASH 2022 Press Briefings: Late-Breaking Abstracts & Optimizing Pediatric Care
ALL
AML
Acute Myeloid Leukemia: Clinical and Epidemiological
Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies
Acute Myeloid Leukemias: More Abstract Links to Oral Paper Presentations
Lymphoma
Mantle Cell, Follicular, and Other B-Cell Lymphomas
Hodgkin Lymphomas and T/NK cell Lymphomas
Aggressive Lymphomas Prospective Therapeutic Trials
Aggressive Lymphomas: Clinical and Epidemiological
Lymphomas: More Abstract Links to Oral Paper Presentations
CML
Myeloproliferative Syndromes
MDS
CLL
Multiple Myeloma
Multiple Myeloma and Plasma cell Dyscrasias: Clinical and Epidemiological
Multiple Myeloma and Plasma Cell Dyscrasias: Clinical-Prospective Therapeutic Trials
Multiple Myeloma: More Abstract Links to Oral Paper Presentations
Cellular Therapies
More Abstract Links to Oral Papers (Transplantation & Gene Therapies & Outcome Research)
45th SAN ANTONIO BREAST CANCER SYMPOSIUM - December 6 - 10, 2022, San Antonio Texas
Interviews von Renate Haidinger, Brustkrebs Deutschland e.V. mit:
Statements vom SABCS 2022 für Journal Onkologie - Kooperationsprojekt Oncoletter-Journal Onkologie
More Studies from the SABCS 2022 Press Briefing
General Sessions 1-5
Cancer Academy Multiples Myelom
ESMO Congress 2022 - 9. - 13. SEPTEMBER - PARIS, FRANCE
Presidential Symposia I-III
Presidential Symposium I
Presidential Symposium II
Presidential Symposium III
BREAST CANCER
Interviews
Breast cancer, early stage
Breast cancer, metastatic
LUNG CANCER & OTHER THORACIC MALIGNANCIES
Statement Highlights Lung Cancer Prof. Dr. med. Miklos Pless, Winterthur
Non-metastatic NSCLC and other thoracic malignancies
NSCLC, metastatic
HEAD & NECK CANCER
Statement Highlights Head and Neck Cancer - Assoz.-Prof. Priv.-Doz. Dr. Thorsten Füreder, Wien
Head & Neck Sessions
GYNAECOLOGICAL CANCERS
Gynaecological Sessions
CNS TUMOURS & SARCOMA
CNS & SARCOMA Sessions
GENITOURINARY TUMOURS
GU tumours, non-prostate
GU tumours, prostate
GASTROINTESTINAL TUMOURS
Statement Highlights Metastatic Gastrointestinal Cancer - Dr. med. Sara De Dosso, Bellinzona & Dr. med. Alexander Siebenhüner, Schaffhausen
GI, upper digestive
GI, lower digestive
HAEMATOLOGICAL MALIGNANCIES
Haematological malignancies Session
MELANOMA AND OTHER SKIN TUMOURS
Statement Highlights Melanoma and other Skin Cancers - Ao. Univ.-Prof. Dr. Christoph Höller, Wien
Melanoma Sessions
INVESTIGATIONAL IMMUNOTHERAPY
INVESTIGATIONAL IMMUNOTHERAPY
BASIC SCIENCE & TRANSLATIONAL RESEARCH & DEVELOPMENTAL THERAPEUTICS
Basic science & translational research sessions & developmental therapeutics
SUPPORTIVE AND PALLIATIVE CARE
Supportive and palliative care sessions
19th International Myeloma Society Annual Meeting - Los Angeles, August 25-27, 2022
Treatment of Relapsed/Refractory Myeloma
Treatment of Newly Diagnosed Myeloma
Cellular and T cell engager Immunotherapy
Disease Monitoring
Myeloma Genomics and cell signaling
Myeloma Microenvironment and Immuneprofiling
Plasma Cell precursor Disorders, QoL, Patient-Reported Outcome & Supportive Care
World Conference on Lung Cancer - AUGUST 6 - 9, 2022, VIENNA, AUSTRIA
Sunday, August 7th Press Briefing
Monday, August 8th Press Briefing
Tuesday, August 9th Press Briefing
OA02 From Locally Advanced to Unresectable NSCLC: Improvement of Multimodality Tx
OA03 Molecular Targeted Treatments
OA05 The Granularity of Lung Cancer Screening Implementation
OA06 Impact of COVID-19 on Cancer Management and Protection from Vaccines
OA07 Is There Still a Role for Chemotherapy Alone in the Management of NSCLC?
OA08 Multidisciplinary Care of the Lung Cancer Patient
OA11 Optimal Patient Selection for Local Therapy in Stage IV NSCLC
OA12 Novel and Combination Strategies for SCLC
OA14 New Techniques to Improve Outcome in ES-NSCLC Patients Treated with Surgery or RT
MA06 - Resectable and Unresectable Locally Advanced Lung Cancer
MA07 - Overcoming Resistance to EGFR Inhibitors
MA08 - Patient Advocacy and Patient Preferences
MA09 - Palliative RT: The Changing Landscape with Immunotherapy & Targeted Rxs
MA10 - Updates in Thymoma
MA12 - Pathology: Tumour Diagnostics
MA13 - Update on ROS1 Inhibitors and New Pathways
MA14 - Palliative and Supportive Care - The Forgotten Trade
ESMO World Congress on Gastrointestinal Cancer (ESMO World GI 2022)
Session I: Opening Session
Session II: Cancer of the Pancreas
Session III: Cancer of the Biliary Tract
Session V: Presentation of Selected Non-Colorectal Cancer Abstracts
Session VIII: Esophageal and Gastric Cancers
Session IX: Hepatocellular Cancer
Session X: Presentation of Selected Colorectal Cancer Abstracts
Session XII: Minisymposium: Special Topics in Young Adults with Cancer
Session XV: Rectal Cancer
Session XVII: Immune Mechanisms and Immunotherapy
Session XVIII: Predicting and Managing Rare Toxicities in GI Cancer Patients
Session XIX: Presentation of Selected Abstracts on GI Cancer
Session XXII: Colorectal Cancer: Metastatic Disease
Session XXIII: Rare GI Tumors – NETs, GISTs, and Anal Cancer
EHA2022 Congress
Webcasts EHA22 Press Briefing
Presidential Symposium
Late Breaking Abstracts Session
Acute lymphoblastic leukemia
Acute myeloid leukemia
Aggressive Non-Hodgkin lymphoma
Chronic lymphocytic leukemia
Chronic myeloid leukemia
Myeloma and other monoclonal gammopathies - Clinical
Gene therapy, cellular immunotherapy and vaccination
Hodgkin lymphoma
Indolent and mantle-cell non-Hodgkin lymphoma
Myelodysplastic syndromes
Myeloproliferative neoplasms
Stem cell transplantation
ASCO Annual Meeting, June 3-7, 2022 - McCormick Place, Chicago
Late-Breaking Abstract -, Plenary - & Highlights of the Day Sessions
Lung Cancer: Oral & Poster Discussion Sessions
Head and Neck Cancer: Oral & Poster Discussion Sessions
Breast Cancer: Oral & Poster Discussion Sessions
Gynecologic Cancer: Oral & Poster Discussion Sessions
Gastrointestinal Cancer: Oral & Poster Discussion Sessions
Sarcoma Cancer: Oral & Poster Discussion Sessions
Melanoma/Skin Cancers: Oral & Poster Discussion Sessions
Central Nervous System Tumors: Oral & Poster Discussion Sessions
Genitourinary Cancer: Oral & Poster Discussion Sessions
Hematologic Malignancies: Oral & Poster Discussion Sessions
Developmental Therapeutics: Oral & Poster Discussion Sessions
Pediatric Oncology: Oral & Poster Discussion Sessions
SAMO Interdisciplinary Workshop on Breast Tumors 2022
Friday 6th May 2022 Session Diagnosis and biology (Chair: S. Aebi)
Friday 6th May 2022 Session Optimum locoregional therapy (Chair: D. Betticher)
Saturday 7th May 2022 Session “Early” (operable) breast cancer (Chair: S. Aebi)
Saturday 7th May 2022 Session Advanced breast cancer, special populations (Chair: H. Bonnefoi)
Druggable in 2022: Wie neue zielgerichtete Therapien die Behandlung bei fortgeschrittenem NSCLC verändern
3rd European Myeloma Network Meeting
Best Abstracts - Oral Presentations
Choice of clinically relevant posters
AGO - MAMMAKARZINOM STATE OF THE ART
AGO State-of-the-Art-Meeting - Interviews
Wie neue zielgerichtete Therapien die Behandlung beim fortgeschrittenen NSCLC (r)evolutionieren.
EBMT (48th Annual Meeting of the European Society for Blood and Marrow Transplantation)
Presidential Symposium
Best abstract awards
EBMT Talks: Best Abstracts
Oral session 8: CAR-T I
Oral session 9: Cellular therapies other than CARs, cell-based immune therapies, stem cell engineering
Oral session 13: CAR-T II
Oral session: Abstract finalists
Other Oral Sessions (Links to sessions only)
SAMO Highlights of the Year 2021
Chair: Rolf Stahel - Tatjana Vlajnic: Progress in Pathology; Walter Weder: Chest surgery new developments; Oliver Gautschi: Chest tumors; Radiotherapy new techniques & Radiotherapy new indications; Cristiana Sessa: Gynecological cancer
Chair: Solange Peters - Steffen Böttcher: Leukaemia; Urban Novak: Lymphoma; Stefan Aebi: Breast cancer; Aurelius Omlin: Urogenital cancer; Gastrointestinal tumors - Martin Hübner: surgical therapy; Gastrointestinal tumors - Ulrich Güller: systemic therapy
Brustrebsinfotag
Brustkrebsinfotag - Vorträge
Brustkrebsinfotag - Interviews
SAMO Masterclass I 2022
Thursday 10th March 2022 - Morning Sessions
Thursday 10th March 2022 - Afternoon Sessions
ASCO Genitourinary Cancers Symposium 2022
General Sessions
Rapid Abstract Sessions
Oral Abstract Sessions
EBMT-EHA 4th European CAR T-Cell Meeting
Best Abstracts
CAR T cell therapy: current status and new perspectives - Satellite Symposium by Bristol Myers Squibb
Sessions
ASCO Gastrointestinal Cancers Symposium
Rapid Abstract Sessions
Oral Abstract Sessions
2021
63rd ASH Annual Meeting and Exposition - December 11-14, 2021
Late-Breaking Abstracts Session
Press Briefing
ALL
AML
Acute Myeloid Leukemia: Clinical and Epidemiological
Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies
Acute Myeloid Leukemias: Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies
Lymphoma
Mantle Cell, Follicular, and Other B-Cell Lymphomas
Hodgkin Lymphomas and T/NK cell Lymphomas
Aggressive Lymphomas Prospective Therapeutic Trials
Aggressive Lymphomas: Clinical and Epidemiological
CML
Myeloproliferative Syndromes
MDS
CLL
Multiple Myeloma
Multiple Myeloma and Plasma cell Dyscrasias: Clinical and Epidemiological
Myeloma and Plasma Cell Dyscrasias: Clinical-Prospective Therapeutic Trials
Cellular Therapies
SAN ANTONIO BREAST CANCER SYMPOSIUM - December 7 - 11, 2021, San Antonio Texas
Interviews von Renate Haidinger, Brustkrebs Deutschland e.V. mit:
General Sessions 1-4
9. Interdisziplinäres Prostatakarzinom-Symposium, St. Gallen, 2. Dezember 2021
Vorträge Block I: Aktuelle Trends in Diagnose und Therapie des Prostatakarzinoms
Vorträge Block II: Indikationsstellung in der Therapie des Prostatakarzinoms und Aspekte der Lebensqualität
Kongressberichte Archiv 2021
Kongressberichte Archiv 2020
Kongressberichte Archiv 2019
Kongressberichte Archiv 2018
Kongressberichte Archiv 2017
Kalender
Krebstherapie
Alle Wirkstoffe
Behandlungsguidelines
Link to Medical Journals
Interaktionsprüfungen
Cancer Cell Line Encyclopedia
Krebserkrankungen (Entstehung, Verlauf, Therapie & Prävention)
Organisationen
Netzwerke
Fachgesellschaften
Info für PatientINNen
Science Board
Live
Kongressberichte
2024
ESMO Congress 2024 - 13. - 17. SEPTEMBER - BARCELONA, SPANIEN
ESMO 2024 Press Conference Recording
ESMO24 - Presidential Symposia I-III
ESMO24 - Presidential Symposia I-III
Presidential Symposium I: Practice-changing trials: Sat, 14.09.24; 16:30 - 18:15; Room Barcelona Auditorium - Hall 2
Presidential Symposium II: Practice-changing trials; Sun, 15.09.24; 16:30 - 18:15; Room Barcelona Auditorium Hall 2
Presidential Symposium III: Eyes to the future; Mon, 16.09.24; 16:30 - 18:15 Room Barcelona Auditorium - Hall 2
BREAST CANCER
Interviews
Interviews von Renate Haidinger, Brustkrebs Deutschland e.V.
Breast cancer, early stage
Proffered paper session: Breast cancer, early stage; Mon, 16.09.24; Time 10:15 - 11:45; Room Barcelona Auditorium - Hall 2
Mini oral session: Breast cancer, early stage; Sat, 14.09.24; 10:15 - 11:45; Room Barcelona Auditorium - Hall 2
Breast cancer, metastatic
Proffered Paper session: Breast cancer, metastatic; Fri, 13.09.24; 16:00 - 17:30; Room Barcelona Auditorium - Hall 2
Mini oral session 1: Breast cancer, metastatic Sun, 15.09.2024; 08:30 - 10:00; Room Barcelona Auditorium - Hall 2
Mini oral session 2: Breast cancer, metastatic; Mon, 16.09.24; 08:30 - 10:00; Room Barcelona Auditorium - Hall 2
LUNG CANCER & OTHER THORACIC MALIGNANCIES
Non-metastatic NSCLC and other thoracic malignancies
Proffered Paper session: Non-metastatic NSCLC; Fri, 13.09.24; 14:00 - 15:30; Room Bilbao Auditorium - Hall 2
Mini oral session 1: Non-metastatic NSCLC; Sun, 15.09.24; 10:15 - 11:30; Room Barcelona Auditorium - Hall 2
Mini oral session 2: Non-metastatic NSCLC; Mon, 16.09.24; 14:45 - 15:45; Room Sevilla Auditorium - Hall 2
NSCLC, metastatic
Proffered paper session: NSCLC metastatic; Sat, 14.09.24; 08:30 - 10:00; Room Barcelona Auditorium - Hall 2
Mini oral session: NSCLC metastatic; Sat, 14.09.24; 10:15 - 11:45; Room Santander Auditorium
HEAD & NECK CANCER
Head & Neck Sessions
Proffered paper session: Head and neck cancer; Sun, 15.09.24; 10:15 - 11:45; Room Valencia Auditorium - Hall 5
Mini oral session: Head and neck cancer; Sat, 14.09.24; 08:30 - 10:00; Room Bilbao Auditorium - Hall 2
GYNAECOLOGICAL CANCERS
Gynaecological Sessions
Proffered paper session: Gynaecological cancers; Sat, 14.09.24; 14:45 - 16:15;Room Sevilla Auditorium - Hall 2
Mini oral session 1: Gynaecological cancers; Sun, 15.09.24; 08:30 - 10:00; Room Burgos Auditorium - Hall 5
Mini oral session 2: Gynaecological cancers; Sun, 15.09.24; 14:45 - 16:15; Room Santander Auditorium - Hall 5
CNS TUMOURS & SARCOMA
CNS & SARCOMA Sessions
Proffered paper session: Sarcoma; Mon, 16.09.24; 14:45 - 16:15; Room Santander Auditorium - Hall 5
Proffered paper session: CNS tumours; Fri, 13.09.24; 14:00 - 15:30; Room Pamplona Auditorium - Hall 3
Mini oral session: CNS tumours; Sun, 15.09.24; 08:30 - 10:00; Room Salamanca Auditorium - Hall 5
Mini oral session: Sarcoma; Fri, 13.09.24; 16:00 - 17:30; Room Alicante Auditorium - Hall 3
GENITOURINARY TUMOURS
Statement Highlights Urothel- und Nierenzellkarzinom: OÄ Dr. Dora Niedersüß-Beke, MBA
GU tumours, non-prostate
Proffered paper session 1: GU tumours, non-prostate; Fri, 13.09.24; 14:00 - 15:30; Room Santander Auditorium - Hall 5
Proffered Paper session 2: GU, non-prostate; Mon, 16.09.24; 08:30 - 10:00; Room Sevilla Auditorium - Hall 2
Mini oral session: GU tumours, non-prostate; Sun, 15.09.24; 08:30 - 10:00; Room Bilbao Auditorium - Hall 2
GU tumours, prostate
Proffered paper session: GU tumours, prostate; Sun, 15.09.24; 14:45 - 16:15; Room Valencia Auditorium - Hall 5
Mini oral session: GU tumours, prostate; Mon, 16.09.24; 10:15 - 11:45; Room Madrid Auditorium - Hall
GASTROINTESTINAL TUMOURS
Statement Assoc.-Prof. Priv.-Doz. Dr. Gerald Prager: Neues bei gastrointestinalen Tumoren
GI, upper digestive
Proffered paper session 1: GI tumours, upper digestive; Fri, 13.09.24; 16:00 - 17:30; Room Sevilla Auditorium - Hall 2
Proffered paper session 2: GI tumours, upper digestive; Sat, 14.09.24; 08:30 - 10:00; Room Madrid Auditorium - Hall 2
Mini oral session: GI tumours, upper; Mon, 16.09.24; 08:30 - 10:00; Room Bilbao Auditorium -
GI, lower digestive
Proffered paper session 1: GI tumours, lower; Sun, 15.09.24; 08:30 - 10:00; Room Sevilla Auditorium - Hall 2
Proffered paper session 2: GI tumours, lower; Sun, 15.09.24; 14:45 - 16:15; Room Madrid Auditorium - Hall 2
Mini oral session: GI tumours, lower; Sat, 14.09.24; 14:45 - 16:15; Room Granada Auditorium - Hall 6
NETs and endocrine tumours
NETs and endocrine tumours Sessions
Proffered paper session: NETs and endocrine tumours; Mon, 16.09.24; 14:45 - 16:15; Room Pamplona Auditorium - Hall 3
Mini oral session: NETs and endocrine tumours; Fri, 13.09.24; 16:00 - 17:30; Room Pamplona Auditorium - Hall 3
HAEMATOLOGICAL MALIGNANCIES
Haematological malignancies Sessions
Mini oral session 1: Haematological malignancies; Fri, 13.09.24; 14:00 - 15:30; Room Toledo Auditorium - Hall 3
Mini oral session 2: Haematological malignancies; Sun, 15.09.24; 08:30 - 10:00; Room Oviedo Auditorium - Hall 3
MELANOMA AND OTHER SKIN TUMOURS
Kommentare Prof. Roger von Moos, Direktor Tumor- und Forschungszentrum, Kantonsspital Graubünden, Chur
Melanoma Sessions
Proffered paper session: Melanoma and other skin tumours; Sat, 14.09.24; 10:15 - 11:45; Room Salamanca Auditorium - Hall 5
Mini oral session: Melanoma and other skin tumours; Sun, 15.09.24; 14:45 - 16:15; Room Oviedo Auditorium - Hall 3
INVESTIGATIONAL IMMUNOTHERAPY
INVESTIGATIONAL IMMUNOTHERAPY
Proffered paper session: Investigational immunotherapy; Fri, 13.09.24; 16:00 - 17:30; Room Burgos Auditorium - Hall 5
Mini oral session: Investigational immunotherapy; Mon, 16.09.24; 10:15 - 11:45; Room Granada Auditorium - Hall 6
SUPPORTIVE AND PALLIATIVE CARE
Supportive and palliative care sessions
Proffered paper session: Supportive and palliative care; Sat, 14.09.24; 14:45 - 16:25; Room Pamplona Auditorium - Hall 3
Mini oral session: Supportive and palliative care; Sun, 15.09.24; 10:15 - 11:45; Room Toledo Auditorium - Hall 3
BASIC SCIENCE & TRANSLATIONAL RESEARCH & DEVELOPMENTAL THERAPEUTICS
Basic science & translational research sessions & developmental therapeutics
Proffered paper session 1: Basic science & Translational research; Sat, 14.09.24; 14:45 - 16:15; Room Salamanca Auditorium - Hall 5
Proffered paper session 2: Basic science & Translational research; Mon, 16.09.24; 14:45 - 16:15; Room Madrid Auditorium - Hall 2
Proffered paper session 1: Developmental therapeutics; Fri, 13.09.24; 16:00 - 17:30; Room Santander Auditorium - Hall 5
Proffered paper session 2: Developmental therapeutics; Sun, 15.09.24; 14:45 - 16:15; Room Salamanca Auditorium - Hall 5
Mini oral session: Developmental therapeutics; Sat, 14.09.24; 14:45 - 16:15; Room Oviedo Auditorium - Hall 3
Mini oral session: Basic science & Translational research; Mon, 16.09.24; 08:30 - 10:00; Room Valencia Auditorium - Hall 5
IASLC 2024 World Conference on Lung Cancer
IASLC World Conference on Lung Cancer Press Briefing Recordings
PL02 Presidential Symposium 1
PL04 Presidential Symposium 2
OA01. Perioperative Strategies 1 - Sep 8 2024 - 10:45AM - 12:00PM - Room 20A
OA02. Redefining First-Line EGFR Therapy - Sep 8 2024 - 10:45AM - 12:00PM - Room 20D
OA04. Antibody Drug Conjugates in SCLC - Sep 8 2024 - 2:00PM - 3:15PM - Room 20A
OA05. Local Consolidative Therapy for Metastatic NSCLC - Sep 8 2024 - 2:00PM - 3:15PM - Room 32AB
OA06. Novel Immunotherapy Strategies and Combinations - Sep 8 2024 - 3:30PM - 4:45PM - Room 20BC
OA08. The New Generation of Cytotoxics - Sep 9 2024 - 10:45AM - 12:00PM - Room 20A
OA09. Trailblazing Targets: New Insights - Sep 9 2024 - 10:45AM - 12:00PM - Room 20D
OA10. DLL3 Targeting BiTE Therapies in SCLC - Sep 9 2024 - 2:00PM - 3:15PM - Room 20A
OA11. Shifting the Bar in the Front Line Immunotherapy Setting - Sep 9 2024 - 2:00PM - 3:15PM - Room 20BC
OA12. Advancing Multimodal Therapies in Stage III NSCLC - Sep 9 2024 - 2:00PM - 3:15PM - Room 32AB
OA13. Perioperative Strategies 2 - Sep 9 2024 - 3:30PM - 4:45PM - Room 20A
OA14. New Horizons in Targeting KRAS G12C - Sep 9 2024 - 3:30PM - 4:45PM - Room 20D
OA16. Transforming Cancer Therapy: Biomarkers and Novel ADCs - Sep 10 2024 - 1:30PM - 2:45PM - Room 20A
OA18. Pleural, Mediastinal and Undifferentiated Thoracic Cancers - Sep 10 2024 - 3:00PM - 4:15PM - Room 30BC
More Links to Oral Sessions
MA01. Advances in Treatment for Stage III NSCLC - Sep 8 2024 - 2:00PM - 3:15PM - Room 20BC
MA06. New Strategies in ALK, ROS1, NTRK, BRAF, and MET NSCLC - Sep 10 2024 - 11:15AM - 12:30PM - Room 20D
MA11. Building on the Foundations of Current Immunotherapies - Sep 10 2024 - 1:30PM - 2:45PM - Room 20BC
MA12. Paving the Path to Precision Oncology: Targeting EGFR and HER2 - Sep 10 2024 - 1:30PM - 2:45PM - Room 20D
MA16. Strategies Beyond Current Immunotherapies - Sep 10 2024 - 3:00PM - 4:15PM - Room 20BC
MA17. Limited-stage SCLC, Novel Immunotherapy Combinations and Biomarkers in SCLC - Sep 10 2024 - 3:00PM - 4:15PM -Room 20D
More Links to Mini Oral Sessions
ESMO Gastrointestinal Cancers Congress 2024
Proffered Paper Session
Proffered Paper Session
Proffered Paper Session
Mini Oral Sessions
Mini Oral sessions
Mini Oral Session 1
Mini Oral session 2
Mini Oral session 3
EHA2024 Hybrid Congress - Madrid, June 13-16, 2024.
Plenary and Late Breaking Abstract Sessions
Plenary and Late Breaking Abstract Sessions
Plenary Session
Late Breaking Abstract Session
Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia
ALL Clinical 1: Immunotherapy: antibodies and CAR-T cells
ALL Clinical 2: Translational insights and new therapeutic options
Acute Myeloid Leukemia
Acute myeloid leukemia
AML - Clinical 1 - Menin inhibitor
AML - Clinical 2 - VEN-AZA
AML - Clinical 3
AML - Clinical 4
Aggressive Non-Hodgkin lymphoma
Aggressive Non-Hodgkin lymphoma
Aggressive lymphoma - Targeted drug therapy
Aggressive lymphoma - CAR-T cell therapy
T cell lymphoma from biology to clinic
Chronic Lymphocytic Leukemia and Related disorders
Chronic lymphocytic leukemia and related disorders
Novel therapies in relapsed and refractory CLL and hairy cell leukemia
Frontline therapy for CLL and Richter
Dr. med. Michael Gregor comments on the CLL 1L therapy in light of EHA24 results and on the SEQUOIA Arm D data
Chronic Myeloid Leukemia
Chronic Myeloid Leukemia
Chronic Myeloid Leukemia
Hodgkin Lymphoma
Hodgkin lymphoma
Hodgkin Lymphoma
Myelodysplastic Syndromes
Myelodysplastic Syndromes
Myelodysplastic Syndromes
Indolent and Mantle-cell non-Hodgkin Lymphoma
Indolent and Mantle-cell non-Hodgkin Lymphoma
Indolent and Mantle-cell non-Hodgkin Lymphoma
Myeloma and other monoclonal gammopathies
Frontline therapy for MM
Frontline therapy for MM
CAR T cell therapy for the treatment of Multiple Myeloma
CAR T cell therapy for the treatment of Multiple Myeloma
Novel agents in RRMM
Novel agents in RRMM
Myeloproliferative Neoplasms
Myeloproliferative Neoplasms
Myeloproliferative neoplasms
Gene Therapy
Stem cell transplantation - Clinical and cell therapy
Stem cell transplantation - Clinical and cell therapy
Cellular Immunotherapy and Vaccination - Biology & Translational Research
Cellular Immunotherapy and Vaccination - Biology & Translational Research
Cellular Immunotherapy and Vaccination
Cellular Immunotherapy and Vaccination
ASCO Annual Meeting 2024 May 31 - June 4, 2024 - McCormick Place, Chicago
Saturday, June 1 - Press Briefings
Interviews in Kooperation mit info@ONCO-SUISSE, moderiert von Prof. Roger von Moos: Schweizer Experten fassen die ASCO Ergebnisse zusammen
Round Table und Interviews von Renate Haidinger, Brustkrebs Deutschland e.V.
Plenary session
Plenary Session Late breaking abstracts - Sunday, June 3, 1PM-4PM, Hall B1
Schweizer Beiträge am ASCO 2024
Links to all Poster Sessions
Breast Cancer
Breast Cancer—Local/Regional/Adjuvant
Breast Cancer—Local/Regional/Adjuvant - Oral Session | Monday, June 3, 3PM-6PM, Hall B1
Breast Cancer —Local/Regional/Adjuvant - Rapid Oral Session | Friday, May 31, 2:45PM-4:15PM, E451
Breast Cancer—Metastatic
Breast Cancer—Metastatic - Oral Session | Saturday, June 1, 3PM-6PM, Hall B1
Breast Cancer — Metastatic - Rapid Oral Session | Monday, June 3, 11.30AM-1PM, Hall D1
Lung Cancer
Lung Cancer - Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers - Oral Session | Monday, June 3, 8AM-11AM, Arie Crown Theater
Lung Cancer —Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers - Rapid Oral Session | Sunday, June 2, 4:30PM-6PM, S406
Lung Cancer—Non-Small Cell Metastatic
Lung Cancer—Non-Small Cell Metastatic - Oral Session | Friday, May 31, 2:45PM-5:15PM, Arie Crown Theater
Lung Cancer —Non-Small Cell Metastatic - Rapid Oral Session | Saturday, June 1, 4:30PM-6PM, S406
Gastrointestinal Cancer
Gastrointestinal Cancer—Colorectal and Anal
Gastrointestinal Cancer—Colorectal and Anal - Oral Session | Sunday, June 2, 8AM-11AM, Arie Crown Theater
Gastrointestinal Cancer— Colorectal and Anal - Rapid Oral Session | Monday, June 3, 1:15PM-2:45PM, Arie Crown Theater
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Gastrointestinal Cancer — Gastroesophageal, Pancreatic, and Hepatobiliary - Oral Session | Tuesday, June 4, 9:45AM-12:45PM, Hall D1
Gastrointestinal Cancer — Gastroesophageal, Pancreatic, and Hepatobiliary - Rapid Oral Session | Monday, June 3, 9:45AM-11:15AM, E451
Genitourinary Cancer
Genitourinary Cancer—Kidney and Bladder
Genitourinary Cancer — Kidney and Bladder Oral | Monday, June 3, 8AM-11AM, Hall B1
Genitourinary Cancer— Kidney and Bladder Rapid Oral| Saturday, June 1, 8AM-9:30AM, S100bc
Genitourinary Cancer—Prostate, Testicular, and Penile
Genitourinary Cancer—Prostate, Testicular, and Penile Oral | Saturday, June 1, 15PM-18PM, Arie Crown Theater
Genitourinary Cancer— Prostate, Testicular, and Penile Rapid Oral| Monday, June 3, 1:15PM-2:45PM, Hall B1
Gynecologic Cancer
Gynecologic Cancer
Gynecologic Cancer Oral | Sunday, June 2, 8AM-11AM, Hall D2
Gynecologic Cancer Rapid Oral | Saturday, June 1, 8AM-930AM, E451
Interviews von Renate Haidinger, Brustkrebs Deutschland e.V. mit Prof. Sven Mahner, Direktor der Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, München
Central Nervous System Tumors
Central Nervous System Tumors
Central Nervous System Tumors Oral | Monday, June 3, 8AM-11AM, S100bc
Central Nervous System Tumors Rapid Oral | Sunday, June 2, 11:30AM-1PM, E350
Head and Neck Cancer
Head and Neck Cancer
Head and Neck Cancer Oral | Tuesday, June 4, 9:45AM-12:45PM, S100a
Head and Neck Cancer Rapid Oral | Monday, June 3, 8AM-9:30AM, E450b
Melanoma/Skin Cancers
Melanoma/Skin Cancers
Melanoma/Skin Cancers Oral | Friday, May 31, 2:45PM-5:45PM, Hall D1
Melanoma/Skin Cancers Rapid Oral | Monday, June 3, 9:45AM-11:15AM, S406
Sarcoma
Sarcoma
Sarcoma Oral | Monday, June 3, 3PM-6PM, S100bc
Sarcoma Rapid Oral | Friday, May 31, 2:45PM-4:15PM, S102
Pediatric Oncology
Pediatric Oncology
Pediatric Oncology I Oral | Sunday, June 2, 8AM-11AM, S100bc
Pediatric Oncology II Oral | Monday, June 3, 11:30AM-2:30PM, S504
Pediatric Oncology Rapid Oral | Sunday, June 2, 4:30PM-6PM, S504
Hematologic Malignancies
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant Oral | Friday, May 31; 2:45PM-5:45PM, S100bc
Hematologic Malignancies— Leukemia, Myelodysplastic Syndromes, and Allotransplant Rapid Oral| Saturday, June 1, 8AM-9:30AM, E450b
Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia Oral | Saturday, June 1, 3PM-6PM, S100bc
Hematologic Malignancies— Lymphoma and Chronic Lymphocytic Leukemia Rapid Oral | Saturday, June 2, 4:30PM-6PM, E450b
Hematologic Malignancies—Plasma Cell Dyscrasia
Hematologic Malignancies — Plasma Cell Dyscrasia Oral | Monday, June 3, 3PM-6PM, Hall D1
Hematologic Malignancies — Plasma Cell Dyscrasia Rapid Oral | Tuesday, June4, 9:45AM-11:15AM, S102
Developmental Therapeutics
Developmental Therapeutics—Immunotherapy
Developmental Therapeutics—Immunotherapy Oral | Monday, June 3. 11:30AM-2:30PM, Hall D2
Developmental Therapeutics—Immunotherapy Rapid Oral | Sunday, June 2, 11:30AM-1:30PM, S406
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology Oral | Saturday, June 1, 3PM-6PM, Hall D1
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology Rapid Oral | Monday, June 3, 8AM-9:30AM, S406
ESGO - 25th European Congress on Gynaecological Oncology
Best Oral Session - Late Breaking Abstracts
Best Oral Session - Cervical Cancer
Mini Oral Session - Cervical Cancer
Best Oral Session - Endometrial Cancer
Mini Oral Session - Endometrial Cancer
Best Oral Session - Ovarian Cancer
Mini Oral Session - Ovarian Cancer
Mini Oral Session - Miscellaneous Cancers
Young Investigator Session
Best Three Minutes Presentations
EBMT-EHA 6th European CAR T-cell Meeting
EBMT-EHA 6th European CAR T-cell Meetings Best Abstracts
ASCO Genitourinary Cancers Symposium
Rapid Oral Abstract Sessions
Rapid Oral Abstract Sessions
Rapid Oral Abstract Session A: Prostate Cancer
Rapid Oral Abstract Session B: Urothelial Carcinoma
Rapid Oral Abstract Session C: Renal Cell, Adrenal, and Testicular Cancers
Oral Abstract Sessions
Oral Abstract Sessions
Oral Abstract Session A: Prostate Cancer
Oral Abstract Session B: Urothelial Carcinoma
Oral Abstract Session C: Renal Cell Cancer
Trials in Progress Poster Sessions
Trials in Progress Poster Sessions
Trials in Progress Poster Session A: Prostate Cancer
Trials in Progress Poster Session B: Urothelial Carcinoma
Trials in Progress Poster Session C: Renal Cell, Adrenal, and Testicular Cancers
ASCO 2024 Gastrointestinal (GI) Cancers Symposium
Rapid Oral Abstract Sessions
Rapid Abstract Sessions
Rapid Oral Abstract Session A: Cancers of the Esophagus and Stomach
Rapid Oral Abstract Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Rapid Oral Abstract Session C: Cancers of the Colon, Rectum, and Anus
Oral Abstract Sessions
Oral Abstract Sessions
Oral Abstract Session A: Cancers of the Esophagus and Stomach
Oral Abstract Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Oral Abstract Session C: Cancers of the Colon, Rectum, and Anus
Trials in Progress Poster Sessions
Trials in Progress Poster Sessions
Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers
Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Trials in Progress Poster Session C: Cancers of the Colon, Rectum, and Anus
2023
65th ASH Annual Meeting and Exposition - December 09-12, 2023
ASH Press Briefings on Late Breaking and other important Abstracts
ASH Press Briefings
ASH Press Briefing 1, Saturday December 9, 2023
ASH Press Briefing 2, Saturday December 9, 2023
ASH Press Briefing 3, Sunday December 10, 2023
ASH Press Briefing 4, Monday December 11, 2023 Late Breaking Abstracts
Late-Breaking Abstracts Session
Acute Lymphoblastic Leukemias
ALL: Clinical and Epidemiological studies
Progress Through Collaboration: Impactful Cooperative Efforts to Optimize Care for ALL - Sunday, December 10, 2023: 12:00 PM-1:30 PM Grand Hall B (Manchester Grand Hyatt San Diego)
ALL: Therapies, Excluding Transplantation and Cellular Immunotherapies
Therapies, Excluding Transplantation and Cellular Immunotherapies: Optimal Frontline Treatment for ALL - Monday, December 11, 2023: 2:45 PM-4:15 PM Grand Hall C (Manchester Grand Hyatt San Diego)
Therapies, Excluding Transplantation and Cellular Immunotherapies: Novel Therapies for ALL - Monday, December 11, 2023: 4:30 PM-6:00 PM Grand Hall D (Manchester Grand Hyatt San Diego)
Acute Myeloid Leukemias
AML: Clinical and Epidemiological studies
Clinical and Epidemiological: Real World Outcomes and Treatment Approaches - Sunday, December 10, 2023: 4:30 PM-6:00 PM Pacific Ballroom Salons 24-26 (Marriott Marquis San Diego Marina)
Clinical and Epidemiological: Innovations in Prognostication - Monday, December 11, 2023: 10:30 AM-12:00 PM Room 6B (San Diego Convention Center)
Clinical and Epidemiological: AML: De Novo and Myelodysplasia-Related - Monday, December 11, 2023: 2:45 PM-4:15 PM Pacific Ballroom Salons 24-26 (Marriott Marquis San Diego Marina)
Clinical and Epidemiological: AML Molecular Targets, Ethnicity, and AI - Monday, December 11, 2023: 4:30 PM-6:00 PM Pacific Ballroom Salons 24-26 (Marriott Marquis San Diego Marina)
AML: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies
Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies: Long-Term Outcomes for Children and Adults Diagnosed With AML/APL - Monday, December 11, 2023: 10:30 AM-12:00 PM Room 6A (San Diego Convention Center)
Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies: Refining Chemotherapy Regimens Plus/Minus MRD Evaluation to Optimize Outcomes in AML - Mon, Dec11, 23: 2:45PM-4:15PM San Diego Ballroom AB Marriott Marquis SD Marina
Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies: Improving Intensive Chemotherapy Regimens for Treatment of AML - Mon, Dec 11, 2023: 4:30PM-6:00PM San Diego Ballroom AB (Marriott Marquis San Diego Marina)
AML: Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies
Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies: Upcoming Therapies in Newly Diagnosed and Relapsed/Refractory AML - Sat, Dec 9, 2023: 9:30 AM-11:00 AM Pacific Ballroom Salons 21-22 (Marriott Marquis San Diego M
Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies: Novel Uses of Approved Therapeutic Agents - Saturday, December 9, 2023: 2:00 PM-3:30 PM Room 6A (San Diego Convention Center)
AML: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis
Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Risk Refinement and Therapy Response - Saturday, December 9, 2023: 9:30 AM-11:00 AM Pacific Ballroom Salons 24-26 (Marriott Marquis San Diego Marina)
Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Biomarkers and Therapeutics - Saturday, December 9, 2023: 2:00 PM-3:30 PM Pacific Ballroom Salons 24-26 (Marriott Marquis San Diego Marina)
Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Minimal Residual Disease and Therapy Response - Sunday, December 10, 2023: 9:30 AM-11:00 AM Marriott Grand Ballroom 8-9 (Marriott Marquis San Diego Marina)
Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Immunologic and Metabolic Biomarkers of Disease Control - Saturday, December 9, 2023: 4:00 PM-5:30 PM Room 6CF (San Diego Convention Center)
Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Deciphering Risk by Genetic and Epigenetic Features - Mon, Dec 11, 2023: 2:45 PM-4:15 PM Pacific Ballroom Salons 15-17 Marriott Marquis San Diego Marina
Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Response Predictors to Targeted Therapies and Transplant - Mon, Dec 11, 2023: 4:30 PM-6:00 PM Pacific Ballroom Salons 15-17 (Marriott Marquis San Diego Marina)
Chronic Myeloid Leukemia
CML: Clinical and Epidemiological studies
CML: Clinical and Epidemiological: Treatment-Free Remission and Prognostication - Sunday, December 10, 2023: 9:30 AM-11:00 AM Pacific Ballroom Salons 21-22 (Marriott Marquis San Diego Marina)
CML: Clinical and Epidemiological: Novel Therapeutic Approaches - Monday, December 11, 2023: 2:45 PM-4:15 PM Pacific Ballroom Salons 18-19 (Marriott Marquis San Diego Marina)
Myeloproliferative Syndromes and Chronic Myeloid Leukemia
MPS and CML: Basic and Translational
MPS and CML: Basic and Translational: Lineage Tracing and Novel Target Discovery - Monday, December 11, 2023: 2:45 PM-4:15 PM Pacific Ballroom Salons 21-22 (Marriott Marquis San Diego Marina)
MPS and CML: Basic and Translational: Oncogenic Drivers and Genetic Models - Monday, December 11, 2023: 4:30 PM-6:00 PM Pacific Ballroom Salons 21-22 (Marriott Marquis San Diego Marina)
MPS and CML: Basic and Translational: Oncogenic Drivers and Genetic Models - Monday, December 11, 2023: 4:30 PM-6:00 PM Pacific Ballroom Salons 21-22 (Marriott Marquis San Diego Marina)
MPS: Clinical and Epidemiological
MPS: Clinical and Epidemiological: Rare Myeloproliferative Neoplasms: Unveiling Promising Pathways and Novel Therapies - Saturday, December 9, 2023: 9:30 AM-11:00 AM Ballroom 20AB (San Diego Convention Center)
MPS: Clinical and Epidemiological: Charting The Future Of MPN Therapies - Sunday, December 10, 2023: 4:30 PM-6:00 PM Ballroom 20CD (San Diego Convention Center)
MPS: Clinical and Epidemiological: Myelofibrosis: New Therapeutic Frontiers - Sunday, December 10, 2023: 4:30 PM-6:00 PM Pacific Ballroom Salons 21-22 (Marriott Marquis San Diego Marina)
MPS: Clinical and Epidemiological: Treatment and Outcomes in MPNs - Monday, December 11, 2023: 10:30 AM-12:00 PM Ballroom 20CD (San Diego Convention Center)
Lymphomas
Lymphomas: Translational
Lymphomas: Translational – Molecular and Genetic: Microenvironment and Methylome in Lymphoma and Misc - Saturday, December 9, 2023: 2:00 PM-3:30 PM Ballroom 20AB (San Diego Convention Center)
Lymphomas: Translational – Molecular and Genetic: Signaling Pathways and MRD in Lymphoma - Sunday, December 10, 2023: 12:00 PM-1:30 PM Harbor Ballroom (Manchester Grand Hyatt San Diego)
Lymphomas: Translational – Molecular and Genetic: Insights into Lymphoma: Unraveling the Molecular Complexity for Precision Diagnostics and Therapeutics - Monday, December 11, 2023: 2:45 PM-4:15 PM Room 6DE (San Diego Convention Center)
Lymphomas: Translational – Non-Genetic: Illuminating the Tumor Microenvironment and Immune Landscape in Lymphoma - Saturday, December 9, 2023: 2:00 PM-3:30 PM Seaport Ballroom ABCD (Manchester Grand Hyatt San Diego)
Lymphomas: Translational – Non-Genetic: Elucidating Biomarkers and Mechanisms of Therapy in Lymphoma - Sunday, December 10, 2023: 9:30 AM-11:00 AM Grand Hall C (Manchester Grand Hyatt San Diego)
Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas
Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Immunotherapy - Sunday, December 10, 2023: 4:30 PM-6:00 PM Grand Hall C (Manchester Grand Hyatt San Diego)
Mantle Cell, Follicular and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Prospective Clinical Trials in Mantle Cell Lymphoma Incorporating Novel Agents - Monday, December 11: 10:30 AM-12 PM Grand Hall B (Manchester Grand Hyatt S
Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Targeted Therapy - Monday, December 11, 2023: 4:30 PM-6:00 PM Grand Hall C (Manchester Grand Hyatt San Diego)
Hodgkin Lymphomas and T/NK cell Lymphomas
Hodgkin Lymphomas and T/NK Cell Lymphomas: Clinical and Epidemiological: Topics in T Cell, Szary and Hodgkin Lymphomas - Saturday, December 9, 2023: 2:00 PM-3:30 PM Grand Hall B (Manchester Grand Hyatt San Diego)
Hodgkin Lymphomas and T/NK Cell Lymphomas: Clinical and Epidemiological: Advances in Treating T Cell Lymphomas - Saturday, December 9, 2023: 4:00 PM-5:30 PM Grand Hall B (Manchester Grand Hyatt San Diego)
Hodgkin Lymphomas and T/NK Cell Lymphomas: Clinical and Epidemiological: Advances in the Treatment of Hodgkin Lymphoma - Sunday, December 10, 2023: 4:30 PM-6:00 PM Grand Hall B (Manchester Grand Hyatt San Diego)
Aggressive Lymphomas
Aggressive Lymphomas: Prospective Therapeutic Trials: Novel Therapies For Relapsed/Refractory Aggressive Lymphoma - Sunday, December 10, 2023: 9:30 AM-11:00 AM Seaport Ballroom ABCD (Manchester Grand Hyatt San Diego)
Aggressive Lymphomas: Prospective Therapeutic Trials: Initial treatment strategies in aggressive B Cell lymphomas - Monday, December 11, 2023: 2:45 PM-4:15 PM Seaport Ballroom ABCD (Manchester Grand Hyatt San Diego)
Aggressive Lymphomas: Clinical and Epidemiological: Real World Data on Outcomes and Treatment-Related Toxicity in B Cell NHL - Saturday, December 9, 2023: 9:30 AM-11:00 AM Seaport Ballroom EFGH (Manchester Grand Hyatt San Diego)
Aggressive Lymphomas: Clinical and Epidemiological: Diagnostic and Prognostic Implications in the Care of Patients With Aggressive Lymphomas - Saturday, December 9, 2023: 2:00 PM-3:30 PM Grand Hall C (Manchester Grand Hyatt San Diego)
Aggressive Lymphomas: Clinical and Epidemiological: Outcomes of Relapsed/Refractory DLBCL Treated with Immunochemotherapy, CAR-T Cell and Novel Agents - Saturday, December 9, 2023: 4:00 PM-5:30 PM Grand Hall C (Manchester Grand Hyatt San Diego)
Aggressive Lymphomas: Clinical and Epidemiological: Treatment to Best Outcomes: Find the Right Therapy for the Right Patient - Sunday, December 10, 2023: 9:30 AM-11:00 AM Grand Hall D (Manchester Grand Hyatt San Diego)
Aggressive Lymphomas: Clinical and Epidemiological: Aiming for the Right Target: Using CAR-T and Bispecifics in Aggressive Lymphomas - Sunday, December 10, 2023: 4:30 PM-6:00 PM Ballroom 20AB (San Diego Convention Center)
Aggressive Lymphomas: Clinical and Epidemiological: Uncommon Aggressive NHL - Monday, December 11, 2023: 4:30 PM-6:00 PM Harbor Ballroom (Manchester Grand Hyatt San Diego)
Chronic Lymphocytic Leukemias
CLL
Chronic Lymphocytic Leukemias: Basic and Translational: Molecular Determinants of CLL and Richter Transformation - Saturday, December 9, 2023: 9:30 AM-11:00 AM Grand Hall B (Manchester Grand Hyatt San Diego)
Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Analysis and Treatment of High Risk and Treatment of Relapsed CLL or Richter Transformation - Saturday, December 9, 2023: 2:00 PM-3:30 PM Grand Hall D (Manchester Grand Hyatt San Diego)
Chronic Lymphocytic Leukemia: Clinical and Epidemiological: New Inhibitors and Cellular Therapies for Treatment of Relapsed CLL - Saturday, December 9, 2023: 4:00 PM-5:30 PM Grand Hall D (Manchester Grand Hyatt San Diego)
Chronic Lymphocytic Leukemia: Clinical and Epidemiological: Frontline Treatment With Targeted Agents in Patients With Chronic Lymphocytic Leukemia - Sunday, December 10, 2023: 4:30 PM-6:00 PM Seaport Ballroom ABCD (Manchester Grand Hyatt)
Myelodysplastic Syndromes
MDS
Myelodysplastic Syndromes – Basic and Translational: Molecular Drivers and Therapeutic Implications - Saturday, December 9, 2023: 4:00 PM-5:30 PM Pacific Ballroom Salons 21-22 (Marriott Marquis San Diego Marina)
Myelodysplastic Syndromes – Clinical and Epidemiological: Treatment Options and Decision Making in Low Risk MDS - Saturday, December 9, 2023: 2:00 PM-3:30 PM Pacific Ballroom Salons 18-19 (Marriott Marquis San Diego Marina)
Myelodysplastic Syndromes – Clinical and Epidemiological: Treatments and Outcome Predictions in High Risk MDS - Saturday, December 9, 2023: 4:00 PM-5:30 PM Pacific Ballroom Salons 18-19 (Marriott Marquis San Diego Marina)
Myelodysplastic Syndromes – Clinical and Epidemiological: Genomic Classification and Prognostication of MDS - Monday, December 11, 2023: 4:30 PM-6:00 PM Pacific Ballroom Salons 18-19 (Marriott Marquis San Diego Marina)
Multiple Myeloma and Plasma Cell Dyscrasias
Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational
Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Spatial Dissection and Multiomics Analysis of the Multiple Myeloma Tumor and Immune Microenvironment - Saturday, Dec 9: 9:30 AM-11AM Harbor Ballroom (Manchester Grand Hya
Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Characterization of the MM and the Tumor Microenvironment - Saturday, December 9, 2023: 4:00 PM-5:30 PM Seaport Ballroom EFGH (Manchester Grand Hyatt San Diego)
Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Characterizing Response and Resistance to CAR-T and TCEs - Sunday, December 10, 2023: 9:30 AM-11:00 AM Harbor Ballroom (Manchester Grand Hyatt San Diego)
Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Molecular Characterization of MM and Precursor Disease States - Sunday, December 10, 2023: 4:30 PM-6:00 PM Harbor Ballroom (Manchester Grand Hyatt San Diego)
Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Advancing Therapies in Multiple Myeloma and Waldenström's Macroglobulinemia - Monday, December 11, 2023: 10:30 AM-12:00 PM Harbor Ballroom (Manchester Grand Hyatt San Diego)
Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Multiple Myleoma Circulating Tumor Cells, Novel Mechanisms, and Immune Interactions - Monday, December 11, 2023: 2:45 PM-4:15 PM Harbor Ballroom (Manchester Grand Hyatt)
Multiple Myeloma: Clinical and Epidemiological
Multiple Myeloma: Clinical and Epidemiological: T Cell Redirecting Therapy Outcomes and Associated Complications - Saturday, December 9, 2023: 9:30 AM-11:00 AM Seaport Ballroom ABCD (Manchester Grand Hyatt San Diego)
Multiple Myeloma: Clinical and Epidemiological: Minimal Residual Disease and Alternative Non-Invasive Bio Marker Evaluations in Myeloma Therapeutics - Saturday, December 9, 2023: 4:00 PM-5:30 PM Harbor Ballroom (Manchester Grand Hyatt San Diego)
Multiple Myeloma: Clinical and Epidemiological: Monoclonal Gammopathies of Determined Significance - Novel Insights on the Relevance of Gammopathies and Misc - Sun, Dec 10: 12 PM-1:30 PM Grand Hall C (Manchester Grand Hyatt San Diego)
Multiple Myeloma: Clinical and Epidemiological: Novel Biomarkers for Treatment Guidance in Multiple Myeloma - Sunday, December 10, 2023: 4:30 PM-6:00 PM Seaport Ballroom EFGH (Manchester Grand Hyatt San Diego)
Multiple Myeloma: Clinical and Epidemiological: Immunological Effects of Sustained Responses in Multiple Myeloma - Monday, December 11, 2023: 10:30 AM-12:00 PM Seaport Ballroom EFGH (Manchester Grand Hyatt San Diego)
Multiple Myeloma: Clinical and Epidemiological: Molecular and Biological Signatures and Predictors of Outcomes - Monday, December 11, 2023: 2:45 PM-4:15 PM Seaport Ballroom EFGH (Manchester Grand Hyatt San Diego)
Multiple Myeloma: Clinical and Epidemiological: Predicting Outcome and Side Effects of Novel Immunotherapies in Multiple Myeloma - Monday, December 11, 2023: 4:30 PM-6:00 PM Seaport Ballroom EFGH (Manchester Grand Hyatt San Diego)
Multiple Myeloma: Prospective Therapeutic Trials
Multiple Myeloma: Prospective Therapeutic Trials: Smoldering and Newly Diagnosed Myeloma - Saturday, December 9, 2023: 2:00 PM-3:30 PM Harbor Ballroom (Manchester Grand Hyatt San Diego)
Multiple Myeloma: Prospective Therapeutic Trials: Relapsed and Refractory Myeloma - Monday, December 11, 2023: 4:30 PM-6:00 PM Seaport Ballroom ABCD (Manchester Grand Hyatt San Diego)
MGUS, Amyloidosis and Other Non-Myeloma Plasma Cell Dyscrasias
MGUS, Amyloidosis & Other Non-Myeloma Plasma Cell Dyscrasias: Clinical & Epidemiological: Screening to Vaccines Spectrum of Plasma Cell Disorders - Sat, Dec 9: 2 PM-3:30 PM Seaport Ballroom EFGH (Manchester Grand Hyatt)
MGUS, Amyloidosis & Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological: From Light Chain to Fibril–Novel Diagnostics to Treatments for Amyloidosis - Sun, Dec 10: 12 PM-1:30 PM Seaport Ballroom EFGH (Manchester Grand
Cellular Immunotherapies
Cellular Immunotherapies: Late Phase and Commercially Available Therapies
Cellular Therapy for B Cell Lymphomas: Prospective Clinical Trials and Real World Data - Saturday, December 9, 2023: 9:30 AM-11:00 AM Room 6A (San Diego Convention Center)
Cellular Immunotherapies: Late Phase and Commercially Available Therapies: Translational Data and Prognostic Factors - Saturday, December 9, 2023: 2:00 PM-3:30 PM Room 6CF (San Diego Convention Center)
Cellular Immunotherapies: Late Phase and Commercially Available Therapies: Prediction and Management of CAR-T Cell Related Toxicity - Saturday, December 9, 2023: 4:00 PM-5:30 PM Room 6B (San Diego Convention Center)
Cellular Immunotherapies: Late Phase and Commercially Available Therapies: Cellular Therapy for Multiple Myeloma, B-cell Acute Lymphoblastic Leukemia and B Cell Lymphomas: Clinical Trial and Real World Evidence - Monday, December 11, 2023: 4:30 PM-6:00 PM
46th SAN ANTONIO BREAST CANCER SYMPOSIUM - December 5 - 9, 2023, San Antonio Texas
Studies presented at the SABCS 2023 Press Briefing
Interviews von Renate Haidinger, Brustkrebs Deutschland e.V.
Kurze Videos mit Expert:innen zu ausgewählten Highlights aus Sitzungen und Vorträgen sowie speziellen Schwerpunktthemen
General Sessions 1-3
General Sessions
GENERAL SESSION 1 | WEDNESDAY, DECEMBER 6 | 9:00AM-12:00PM CT
GENERAL SESSION 2 | THURSDAY, DECEMBER 7 | 8:15AM-11:15AM CT
GENERAL SESSION 3 | FRIDAY, DECEMBER 8 | 8:15AM-11:15AM CT
Rapid Fire Sessions 1&2
Rapid Fire Sessions 1&2
Rapid Fire Session 1 | WEDNESDAY, DECEMBER 6 | 12:15-1:00PM CT
Rapid Fire Session 2 | THURSDAY, DECEMBER 7 | 12:00-12:45PM CT
Late Breaking Abstracts Oral Session
Late Breaking Abstracts Oral Session
Late Breaking Abstracts Oral Session| FRIDAY, DECEMBER 8 | 12:00- 12:45PM CT
POSTER SPOTLIGHT SESSIONS 1-18
POSTER SPOTLIGHT SESSIONS
Poster Spotlight Session 1: Less is More: Minimizing Surgical Treatment in Patients with Early Stage Breast Cancer
Poster Spotlight Session 2: Improving QOL and Care Delivery for the Breast Cancer Patient
Poster Spotlight Session 3: Insights from Single Cell, Spatial, and Artificial Intelligence Approaches
Poster Spotlight Session 4: Gaps in the Timing, Treatment Selection, and Supportive Services for Cancer Care
Poster Spotlight Session 5: Shining a New Light on Breast Cancer: Novel Molecular and Functional Imaging Approaches to Detect and Characterize Breast Cancer
Poster Spotlight Session 6: Prognostic and Predictive Uses of Cell Free DNA
Poster Spotlight Session 7: Prevention
Poster Spotlight Session 8: Antibody Drug Conjugates: Where are We Headed?
Poster Spotlight Session 9: Exploiting Tumor Biology in HER2-positive Breast Cancer to Escalate or De-escalate Neoadjuvant Therapy
Poster Spotlight Session 10: Refining Prediction of Cancer Risk and Outcomes
Poster Spotlight Session 11: CNS Disease in Breast Cancer: Where are We Now and Can We do Better?
Poster Spotlight Session 12: Putting Brakes on the Cell Cycle: Understanding Mechanisms Governing CDK 4/6 Inhibitor Resistance and Role for Novel Therapeutic Strategies
Poster Spotlight Session 13: Special Populations: Pregnancy, Male and Geriatric Patients
Poster Spotlight Session 14: Setting Expectations for Toxicities Related to I/O Therapy
Poster Spotlight Session 15: Novel Nuclear Receptor Targeting Therapies
Poster Spotlight Session 16: Enhancing Immunotherapy for Triple Negative Breast Cancer: Novel therapies and Biomarkers
Poster Spotlight Session 17: Biomarkers of Response and/or Resistance to Endocrine Based Therapies: Implications for Treatment Approaches
Poster Spotlight Session 18: Disparate Care Calls for Desperate Measures: Understanding Gaps in Quality of Care and Opportunities to Improve it
ESMO Congress 2023 - 20. - 24. OKTOBER - MADRID, SPANIEN
ESMO23 - Presidential Symposia I-III
ESMO23 - Presidential Symposia I-III
Presidential Symposium I - Sat, 21.10.2023; 16:30 - 18:15
Presidential Symposium II - Sun, 22.10.2023; 16:30 - 18:15
Presidential Symposium III - Mon, 23.10.2023; 16:30 - 18:15
BREAST CANCER
Interviews
Interviews von Renate Haidinger, Brustkrebs Deutschland e.V.
Breast cancer, early stage
Proffered Paper session: Breast cancer, early stage - Fri, 20.10.2023; 14:00 - 15:40
Mini Oral session: Breast cancer, early stage - Mon, 23.10.2023; 16:30 - 18:00
Breast cancer, metastatic.
Proffered Paper session: Breast cancer, metastatic - Sat, 21.10.2023; 10:15 - 11:35
Mini Oral session: Breast cancer, metastatic - Sun, 22.10.2023; 08:30 - 09:55
LUNG CANCER & OTHER THORACIC MALIGNANCIES
Statement ESMO Highlights Lungenkrebs Prof. Dr. med. Alessandra Curioni-Fontecedro, Fribourg
Statement
Non-metastatic NSCLC and other thoracic malignancies
Proffered Paper session: Non-metastatic NSCLC and other thoracic malignancies - Fri, 20.10.2023; 14:00 - 15:45
Mini Oral session 1: Non-metastatic NSCLC and other thoracic malignancies - Sat, 21.10.2023; 14:45 - 16:15
Mini Oral session 2: Non-metastatic NSCLC and other thoracic malignancies - Mon, 23.10.2023; 14:45 - 15:55
NSCLC, metastatic
Proffered Paper session: NSCLC, metastatic - Fri, 20.10.2023; 16:00 - 17:30
Mini Oral session 1: NSCLC, metastatic - Sat, 21.10.2023; 08:30 - 10:00
Mini Oral session 2: NSCLC, metastatic - Sun, 22.10.2023; 08:30 - 10:00
HEAD & NECK CANCER
Statement Highlights Head and Neck Cancer - Assoz.-Prof. Priv.-Doz. Dr. Thorsten Füreder, Wien
Head & Neck Sessions
Proffered Paper session: Head & neck cancer - Mon, 23.10.2023; 08:30 - 09:55
Mini Oral session: Head & neck cancer - Sat, 21.10.2023; 10:15 - 11:15
GYNAECOLOGICAL CANCERS
Interviews von Renate Haidinger, Brustkrebs Deutschland e.V. mit Prof. Dr. med. Sven Mahner - Highlights Gynäkologische Tumoren
Interviews
Gynaecological Sessions
Proffered Paper session 1: Gynaecological cancers - Fri, 20.10.2023; 16:00 - 17:30
Proffered Paper session 2: Gynaecological cancers - Sat, 21.10.2023: 08:45 - 10:00
Mini Oral session: Gynaecological cancers - Sun, 22.10.2023; 10:15 - 11:55
CNS TUMOURS & SARCOMA
CNS & SARCOMA Sessions
Proffered Paper session: CNS tumours - Fri, 20.10.2023: 16:00 - 17:30
Proffered Paper session: Sarcoma - Sun, 22.10.2023; 08:30 - 10:00
Mini Oral session: CNS tumours - Sat, 21.10.2023; 10:15 - 11:45
Mini Oral session: Sarcoma - Sat, 21.10.2023; 10:15 - 11:45
GENITOURINARY TUMOURS
GU tumours, non-prostate.
Proffered Paper sessions 1: GU tumours, non-prostate - Sat, 21.10.2023; 08:30 - 09:50
Proffered Paper session 2: GU tumours, non-prostate - Sat, 21.10.2023; 14:45 - 16:10
Mini Oral session: GU tumours, non-prostate - Sun, 22.10.2023; 10:15 - 11:45
GU tumours, prostate
Proffered Paper session: GU tumours, prostate - Fri, 20.10.2023; 16:00 - 17:20
Mini Oral session: GU tumours, prostate - Sun, 22.10.2023; 08:30 - 09:35
GASTROINTESTINAL TUMOURS
GI, upper digestive
Proffered Paper sessions 1: GI, upper digestive - Fri, 20.10.2023; 14:00 - 15:40
Proffered Paper sessions 2: GI, upper digestive - Sun, 22.10.2023; 10:15 - 11:45
Mini Oral session: GI, upper digestive - Sat, 21.10.2023; 16:30 - 18:10
GI, lower digestive
Proffered Paper session: GI, lower digestive - Mon, 23.10.2023; 08:30 - 10:00
Mini Oral session: GI, lower digestive - Sun, 22.10.2023; 14:45 - 16:20
NETs and endocrine tumours
NETs and endocrine tumours Sessions
Proffered Paper session: NETs and endocrine tumours - Sun, 22.10.2023; 08:30 - 10:00
Mini Oral session: NETs and endocrine tumours - Sun, 22.10.2023; 16:30 - 18:00
HAEMATOLOGICAL MALIGNANCIES
Haematological malignancies Sessions
Proffered paper session: Haematological malignancies - Sun, 22.10.2023; 16:30 - 18:00
MELANOMA AND OTHER SKIN TUMOURS
Melanoma Sessions
Proffered Paper session: Melanoma and other skin tumours - Mon, 23.10.2023; 08:30 - 10:00
Mini Oral session: Melanoma and other skin tumours - Sat, 21.10.2023; 14:45 - 16:10
INVESTIGATIONAL IMMUNOTHERAPY
INVESTIGATIONAL IMMUNOTHERAPY
Proffered Paper session: Investigational immunotherapy - Mon, 23.10.2023; 10:15 - 11:40
Mini Oral session: Investigational immunotherapy - Sat, 21.10.2023; 16:30 - 17:50
BASIC SCIENCE & TRANSLATIONAL RESEARCH & DEVELOPMENTAL THERAPEUTICS (Kopie)
Basic science & translational research sessions & developmental therapeutics
Proffered Paper session 1: Basic science & translational research - Sat, 21.10.2023; 10:15 - 11:45
Proffered Paper session 2: Basic science & translational research - Sat, 21.10.2023; 14:45 - 16:15
Proffered Paper session: Developmental therapeutics - Sun, 22.10.2023; 08:30 - 10:00
Mini Oral session: Developmental therapeutics - Mon, 23.10.2023; 16:30 - 18:00
Mini Oral session: Basic science & translational research - Sun, 22.10.2023; 08:30 - 10:00
SUPPORTIVE AND PALLIATIVE CARE
Supportive and palliative care sessions
Proffered Paper session: Supportive and palliative care - Fri, 20.10.2023; 16:00 - 17:20
Mini Oral session: Supportive and palliative care - Sat, 21.10.2023; 14:45 - 16:15
IASLC 2023 World Conference on Lung Cancer
IASLC World Conference on Lung Cancer Press Briefing Recordings
Oral Session: Advancing Immunotherapy in ES-SCLC
Oral Session: Evolving Landscape in Mesothelioma
Oral Session: Newer Generation Treatments for EGFR, ALK and ROS1
Oral Session: Antibody Drug Conjugates: The Next Tsunami
Oral Session: Immunotherapy for Advanced NSCLC
Oral Session: Pushing the Boundaries: Adjuvant & Neoadjuvant Approaches in Early NSCLC
Oral Session: Immune Checkpoint Therapy: Long Term Follow Up
Oral Session: MET Matters in NSCLC
Oral Session: Integration of Local Therapies with Modern Immune Checkpoint Inhibitors and Targeted Therapies in Metastatic NSCLC: When and How?
Oral Session: Next Steps in Locally Advanced NSCLC: Optimizing Techniques & Choosing Populations That Benefit
More Links to Oral Sessions
Mini Oral Session: Targeted Therapy: KRAS and Beyond
Mini Oral Session: Mediastinal Lumps and Bumps
Mini Oral Session: New Technology and Innovations in Early Stage Lung Cancer
Mini Oral Session: Targeted Therapy: EGFR and HER2
Mini Oral Session: Bringing New Discoveries into Early Phase Clinical Trials
Mini Oral Session: Innovations in the Treatment of Stage III NSCLC
Mini Oral Session: Current Standards and Future Directions in Mesothelioma
Mini Oral Session: Refining Practice and Redefining Standards in SCLC
More Links to Mini Oral Sessions
ESMO World Congress on Gastrointestinal Cancer (ESMO World GI 2023)
Session II: Cancer of the Pancreas
Session III: Cancer of the Biliary Tract
Session V: Presentation of Selected Abstracts – Biliary Tract and Pancreatic Cancer
Session VI: Presentation of Selected Abstracts - Esophageal and Stomach Cancers
Session VIII: Esophageal and Gastric Cancers
Session IX: Hepatocellular Cancer
Session XI: Presentation of Selected Abstracts: Colorectal Cancer
Session XVIII: Immune Mechanisms and Microbiome in GI Tumors
Session XIX: Predicting and Managing Rare Toxicities in Patients With GI Cancers
Session XX: Presentation of Selected Abstracts: Metastatic Colorectal Cancer
Session XXIII: Colorectal Cancer: Metastatic Disease
EHA2023 Congress
Plenary Session
EHA 2023 Press Briefing, Friday, June 9
Late Breaking Abstracts Session
Acute lymphoblastic leukemia
Acute myeloid leukemia
Aggressive Non-Hodgkin lymphoma
Chronic lymphocytic leukemia
Chronic myeloid leukemia
Myeloma and other monoclonal gammopathies - Clinical
Gene therapy, cellular immunotherapy and vaccination
Hodgkin lymphoma
Indolent and mantle-cell non-Hodgkin lymphoma/Waldenström
Myelodysplastic syndromes
Myeloproliferative neoplasms
Stem cell transplantation
ASCO Annual Meeting, June 2-6, 2023 - McCormick Place, Chicago
Late-Breaking Abstract -, Plenary - & Highlights of the Day Sessions
Interviews in Kooperation mit info@ONCO-SUISSE, moderiert von Prof. Roger von Moos: Schweizer Experten fassen die ASCO Ergebnisse zusammen
Round Table und Interviews von Renate Haidinger, Brustkrebs Deutschland e.V.
Saturday, June 3 & Sunday June 4, On-Site Press Briefings
Lung Cancer: Oral & Poster Discussion Sessions
Head and Neck Cancer: Oral & Poster Discussion Sessions
Breast Cancer: Oral & Poster Discussion Sessions
Gynecologic Cancer: Oral & Poster Discussion Sessions
Gastrointestinal Cancer: Oral & Poster Discussion Sessions
Sarcoma Cancer: Oral & Poster Discussion Sessions.
Melanoma/Skin Cancers: Oral & Poster Discussion Sessions.
Central Nervous System Tumors: Oral & Poster Discussion Sessions.
Genitourinary Cancer: Oral & Poster Discussion Sessions
Hematologic Malignancies: Oral & Poster Discussion Sessions
Developmental Therapeutics: Oral & Poster Discussion Sessions
Pediatric Oncology: Oral & Poster Discussion Sessions
Comprehensive Cancer Center Zürich: Patientenakademie – Brustkrebs
Neuigkeiten in der Behandlung und Nachsorge bei Brustkrebs
18th St.Gallen International Breast Cancer Conference 2023 (SGBCC)
Interviews von Renate Haidinger, Brustkrebs Deutschland e.V. mit:
ASCO Genitourinary Cancers Symposium 2023
General Sessions
Rapid Abstract Sessions
Oral Abstract Sessions
Statements zu den Highlights des ASCO-GU
ASCO 2023 Gastrointestinal (GI) Cancers Symposium
Rapid Abstract Sessions
Oral Abstract Sessions
Links to more Abstracts
2022
64th ASH Annual Meeting and Exposition - December 10-13, 2022
Plenary Scientific Session
Late-Breaking Abstracts Session
Press Briefing
ASH 2022 Press Briefings: Treating Blood Cancers: Changing the Status Quo & New Drugs, New Targets
ASH 2022 Press Briefings: Late-Breaking Abstracts & Optimizing Pediatric Care
ALL
AML
Acute Myeloid Leukemia: Clinical and Epidemiological
Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies
Acute Myeloid Leukemias: More Abstract Links to Oral Paper Presentations
Lymphoma
Mantle Cell, Follicular, and Other B-Cell Lymphomas
Hodgkin Lymphomas and T/NK cell Lymphomas
Aggressive Lymphomas Prospective Therapeutic Trials
Aggressive Lymphomas: Clinical and Epidemiological
Lymphomas: More Abstract Links to Oral Paper Presentations
CML
Myeloproliferative Syndromes
MDS
CLL
Multiple Myeloma
Multiple Myeloma and Plasma cell Dyscrasias: Clinical and Epidemiological
Multiple Myeloma and Plasma Cell Dyscrasias: Clinical-Prospective Therapeutic Trials
Multiple Myeloma: More Abstract Links to Oral Paper Presentations
Cellular Therapies
More Abstract Links to Oral Papers (Transplantation & Gene Therapies & Outcome Research)
45th SAN ANTONIO BREAST CANCER SYMPOSIUM - December 6 - 10, 2022, San Antonio Texas
Interviews von Renate Haidinger, Brustkrebs Deutschland e.V. mit:
Statements vom SABCS 2022 für Journal Onkologie - Kooperationsprojekt Oncoletter-Journal Onkologie
More Studies from the SABCS 2022 Press Briefing
General Sessions 1-5
Cancer Academy Multiples Myelom
ESMO Congress 2022 - 9. - 13. SEPTEMBER - PARIS, FRANCE
Presidential Symposia I-III
Presidential Symposium I
Presidential Symposium II
Presidential Symposium III
BREAST CANCER
Interviews
Interviews von Renate Haidinger, Brustkrebs Deutschland e.V.
Breast cancer, early stage
Proffered Paper session: Breast cancer, early stage
Mini Oral session: Breast cancer, early stage
Breast cancer, metastatic
Proffered Paper session: Breast cancer, metastatic
Mini Oral session: Breast cancer, metastatic
LUNG CANCER & OTHER THORACIC MALIGNANCIES
Statement Highlights Lung Cancer Prof. Dr. med. Miklos Pless, Winterthur
Statement Highlights Lung Cancer Prof. Dr. med. Miklos Pless, Winterthur
Non-metastatic NSCLC and other thoracic malignancies
Proffered Paper session: Non-metastatic NSCLC and other thoracic malignancies
Mini Oral session: Non-metastatic NSCLC and other thoracic malignancies
NSCLC, metastatic
Proffered Paper session: NSCLC, metastatic
Mini Oral session: NSCLC, metastatic
HEAD & NECK CANCER
Statement Highlights Head and Neck Cancer - Assoz.-Prof. Priv.-Doz. Dr. Thorsten Füreder, Wien
Head & Neck Sessions
Proffered Paper session: Head & neck cancer
Mini Oral session: Head & neck cancer
GYNAECOLOGICAL CANCERS
Gynaecological Sessions
Proffered Paper session: Gynaecological cancers
Mini Oral session 1: Gynaecological cancers
Mini Oral session 2: Gynaecological cancers
CNS TUMOURS & SARCOMA
CNS & SARCOMA Sessions
Proffered Paper session: CNS tumours
Mini Oral session: CNS tumours
Mini Oral session: Sarcoma
GENITOURINARY TUMOURS
GU tumours, non-prostate
Proffered Paper sessions 1 & 2: GU tumours, non-prostate
Mini Oral session 1: GU tumours, non-prostate
Mini Oral session 2: GU tumours, non-prostate
GU tumours, prostate
Proffered Paper session: GU tumours, prostate
Mini Oral session: GU tumours, prostate
GASTROINTESTINAL TUMOURS
Statement Highlights Metastatic Gastrointestinal Cancer - Dr. med. Sara De Dosso, Bellinzona & Dr. med. Alexander Siebenhüner, Schaffhausen
GI, upper digestive
Proffered Paper sessions 1 & 2: GI, upper digestive
Mini Oral session: GI, upper digestive
GI, lower digestive
Proffered Paper sessions 1 & 2: GI, lower digestive
Mini Oral session: GI, lower digestive
HAEMATOLOGICAL MALIGNANCIES
Haematological malignancies Session
Mini Oral session: Haematological malignancies
MELANOMA AND OTHER SKIN TUMOURS
Statement Highlights Melanoma and other Skin Cancers - Ao. Univ.-Prof. Dr. Christoph Höller, Wien
Melanoma Sessions
Proffered Paper sessions 1 & 2: Melanoma and other skin tumours
Mini Oral session: Melanoma and other skin tumours
INVESTIGATIONAL IMMUNOTHERAPY
INVESTIGATIONAL IMMUNOTHERAPY
Proffered Paper session: Investigational immunotherapy
Mini Oral session: Investigational immunotherapy
BASIC SCIENCE & TRANSLATIONAL RESEARCH & DEVELOPMENTAL THERAPEUTICS
Basic science & translational research sessions & developmental therapeutics
Proffered Paper session: Basic science & translational research
Mini Oral session: Basic science & translational research
Mini Oral session: Developmental therapeutics
SUPPORTIVE AND PALLIATIVE CARE
Supportive and palliative care sessions
Proffered Paper session: Supportive and palliative care
Mini Oral session: Supportive and palliative care
19th International Myeloma Society Annual Meeting - Los Angeles, August 25-27, 2022
Treatment of Relapsed/Refractory Myeloma
Treatment of Newly Diagnosed Myeloma
Cellular and T cell engager Immunotherapy
Disease Monitoring
Myeloma Genomics and cell signaling
Myeloma Microenvironment and Immuneprofiling
Plasma Cell precursor Disorders, QoL, Patient-Reported Outcome & Supportive Care
World Conference on Lung Cancer - AUGUST 6 - 9, 2022, VIENNA, AUSTRIA
Sunday, August 7th Press Briefing
Monday, August 8th Press Briefing
Tuesday, August 9th Press Briefing
OA02 From Locally Advanced to Unresectable NSCLC: Improvement of Multimodality Tx
OA03 Molecular Targeted Treatments
OA05 The Granularity of Lung Cancer Screening Implementation
OA06 Impact of COVID-19 on Cancer Management and Protection from Vaccines
OA07 Is There Still a Role for Chemotherapy Alone in the Management of NSCLC?
OA08 Multidisciplinary Care of the Lung Cancer Patient
OA11 Optimal Patient Selection for Local Therapy in Stage IV NSCLC
OA12 Novel and Combination Strategies for SCLC
OA14 New Techniques to Improve Outcome in ES-NSCLC Patients Treated with Surgery or RT
MA06 - Resectable and Unresectable Locally Advanced Lung Cancer
MA07 - Overcoming Resistance to EGFR Inhibitors
MA08 - Patient Advocacy and Patient Preferences
MA09 - Palliative RT: The Changing Landscape with Immunotherapy & Targeted Rxs
MA10 - Updates in Thymoma
MA12 - Pathology: Tumour Diagnostics
MA13 - Update on ROS1 Inhibitors and New Pathways
MA14 - Palliative and Supportive Care - The Forgotten Trade
ESMO World Congress on Gastrointestinal Cancer (ESMO World GI 2022)
Session I: Opening Session
Session II: Cancer of the Pancreas
Session III: Cancer of the Biliary Tract
Session V: Presentation of Selected Non-Colorectal Cancer Abstracts
Session VIII: Esophageal and Gastric Cancers
Session IX: Hepatocellular Cancer
Session X: Presentation of Selected Colorectal Cancer Abstracts
Session XII: Minisymposium: Special Topics in Young Adults with Cancer
Session XV: Rectal Cancer
Session XVII: Immune Mechanisms and Immunotherapy
Session XVIII: Predicting and Managing Rare Toxicities in GI Cancer Patients
Session XIX: Presentation of Selected Abstracts on GI Cancer
Session XXII: Colorectal Cancer: Metastatic Disease
Session XXIII: Rare GI Tumors – NETs, GISTs, and Anal Cancer
EHA2022 Congress
Webcasts EHA22 Press Briefing
Presidential Symposium
Late Breaking Abstracts Session
Acute lymphoblastic leukemia
Acute myeloid leukemia
Aggressive Non-Hodgkin lymphoma
Chronic lymphocytic leukemia
Chronic myeloid leukemia
Myeloma and other monoclonal gammopathies - Clinical
Gene therapy, cellular immunotherapy and vaccination
Hodgkin lymphoma
Indolent and mantle-cell non-Hodgkin lymphoma
Myelodysplastic syndromes
Myeloproliferative neoplasms
Stem cell transplantation
ASCO Annual Meeting, June 3-7, 2022 - McCormick Place, Chicago
Late-Breaking Abstract -, Plenary - & Highlights of the Day Sessions
Lung Cancer: Oral & Poster Discussion Sessions
Head and Neck Cancer: Oral & Poster Discussion Sessions
Breast Cancer: Oral & Poster Discussion Sessions
Gynecologic Cancer: Oral & Poster Discussion Sessions
Gastrointestinal Cancer: Oral & Poster Discussion Sessions
Sarcoma Cancer: Oral & Poster Discussion Sessions
Melanoma/Skin Cancers: Oral & Poster Discussion Sessions
Central Nervous System Tumors: Oral & Poster Discussion Sessions
Genitourinary Cancer: Oral & Poster Discussion Sessions
Hematologic Malignancies: Oral & Poster Discussion Sessions
Developmental Therapeutics: Oral & Poster Discussion Sessions
Pediatric Oncology: Oral & Poster Discussion Sessions
SAMO Interdisciplinary Workshop on Breast Tumors 2022
Friday 6th May 2022 Session Diagnosis and biology (Chair: S. Aebi)
Friday 6th May 2022 Session Optimum locoregional therapy (Chair: D. Betticher)
Saturday 7th May 2022 Session “Early” (operable) breast cancer (Chair: S. Aebi)
Saturday 7th May 2022 Session Advanced breast cancer, special populations (Chair: H. Bonnefoi)
Druggable in 2022: Wie neue zielgerichtete Therapien die Behandlung bei fortgeschrittenem NSCLC verändern
3rd European Myeloma Network Meeting
Best Abstracts - Oral Presentations
Choice of clinically relevant posters
AGO - MAMMAKARZINOM STATE OF THE ART
AGO State-of-the-Art-Meeting - Interviews
Wie neue zielgerichtete Therapien die Behandlung beim fortgeschrittenen NSCLC (r)evolutionieren.
EBMT (48th Annual Meeting of the European Society for Blood and Marrow Transplantation)
Presidential Symposium
Best abstract awards
EBMT Talks: Best Abstracts
Oral session 8: CAR-T I
Oral session 9: Cellular therapies other than CARs, cell-based immune therapies, stem cell engineering
Oral session 13: CAR-T II
Oral session: Abstract finalists
Other Oral Sessions (Links to sessions only)
SAMO Highlights of the Year 2021
Chair: Rolf Stahel - Tatjana Vlajnic: Progress in Pathology; Walter Weder: Chest surgery new developments; Oliver Gautschi: Chest tumors; Radiotherapy new techniques & Radiotherapy new indications; Cristiana Sessa: Gynecological cancer
Chair: Solange Peters - Steffen Böttcher: Leukaemia; Urban Novak: Lymphoma; Stefan Aebi: Breast cancer; Aurelius Omlin: Urogenital cancer; Gastrointestinal tumors - Martin Hübner: surgical therapy; Gastrointestinal tumors - Ulrich Güller: systemic therapy
Brustrebsinfotag
Brustkrebsinfotag - Vorträge
Brustkrebsinfotag - Interviews
SAMO Masterclass I 2022
Thursday 10th March 2022 - Morning Sessions
Thursday 10th March 2022 - Afternoon Sessions
ASCO Genitourinary Cancers Symposium 2022
General Sessions
Rapid Abstract Sessions
Oral Abstract Sessions
EBMT-EHA 4th European CAR T-Cell Meeting
Best Abstracts
CAR T cell therapy: current status and new perspectives - Satellite Symposium by Bristol Myers Squibb
Sessions
ASCO Gastrointestinal Cancers Symposium
Rapid Abstract Sessions
Oral Abstract Sessions
2021
63rd ASH Annual Meeting and Exposition - December 11-14, 2021
Late-Breaking Abstracts Session
Press Briefing
ALL
AML
Acute Myeloid Leukemia: Clinical and Epidemiological
Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies
Acute Myeloid Leukemias: Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies
Lymphoma
Mantle Cell, Follicular, and Other B-Cell Lymphomas
Hodgkin Lymphomas and T/NK cell Lymphomas
Aggressive Lymphomas Prospective Therapeutic Trials
Aggressive Lymphomas: Clinical and Epidemiological
CML
Myeloproliferative Syndromes
MDS
CLL
Multiple Myeloma
Multiple Myeloma and Plasma cell Dyscrasias: Clinical and Epidemiological
Myeloma and Plasma Cell Dyscrasias: Clinical-Prospective Therapeutic Trials
Cellular Therapies
SAN ANTONIO BREAST CANCER SYMPOSIUM - December 7 - 11, 2021, San Antonio Texas
Interviews von Renate Haidinger, Brustkrebs Deutschland e.V. mit:
General Sessions 1-4
9. Interdisziplinäres Prostatakarzinom-Symposium, St. Gallen, 2. Dezember 2021
Vorträge Block I: Aktuelle Trends in Diagnose und Therapie des Prostatakarzinoms
Vorträge Block II: Indikationsstellung in der Therapie des Prostatakarzinoms und Aspekte der Lebensqualität
Kongressberichte Archiv 2021
Kongressberichte Archiv 2020
Kongressberichte Archiv 2019
Kongressberichte Archiv 2018
Kongressberichte Archiv 2017
Kalender
Krebstherapie
Alle Wirkstoffe
Behandlungsguidelines
Link to Medical Journals
Interaktionsprüfungen
Cancer Cell Line Encyclopedia
Krebserkrankungen (Entstehung, Verlauf, Therapie & Prävention)
Organisationen
Netzwerke
Fachgesellschaften
Info für PatientINNen
Science Board
You are using an outdated browser. The website may not be displayed correctly.
Close